| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Okt―15 |
Antibody evasion and receptor binding of SARS-CoV-2 LP.8.1.1, NB.1.8.1, XFG, and related subvariants |
Ian A. Mellis, Madeline Wu, Hsiang Hong, Chih-Chen Tzang, Anthony Bowen, Qian Wang, Carmen Gherasim, Virginia M. Pierce, Jayesh G. Shah, Lawrence J. Purpura, Michael T. Yin, Aubree Gordon, Yicheng Guo, David D. Ho |
| 2 |
[GO] |
2025―Aug―13 |
Signatures of omicron-like adaptation in early SARS-CoV-2 variants and chronic infection |
Mark Tsz Kin Cheng, Mazharul Altaf, Jesu Castin, Ann-Kathrin Reuschl, Benjamin L. Sievers, Kimia Kamelian, Dejan Mesner, Rebecca B. Morse, Adam Abdullahi, Bo Meng, Kata Csiba, Steven A. Kemp, Darren P. Martin, Clare Jolly, Christopher Ruis, Lipi Thukral, Ravindra K. Gupta |
| 3 |
[GO] |
2025―Jul―22 |
Structure of a SARS-CoV-2 spike S2 subunit in a pre-fusion, open conformation |
Eduardo Olmedillas, Roshan R. Rajamanickam, Ruben Diaz Avalos, Fernanda Ana-Sosa-Batiz, Dawid Zyla, Michelle A. Zandonatti, Stephanie S. Harkins, Sujan Shresta, Kathryn M. Hastie, Erica Ollmann Saphire |
| 4 |
[GO] |
2025―Jul―08 |
Structural serology of polyclonal antibody responses to mRNA-1273 and NVX-CoV2373 COVID-19 vaccines |
Sandhya Bangaru, Abigail M. Jackson, Jeffrey Copps, Monica L. Fernández-Quintero, Jonathan L. Torres, Sara T. Richey, Bartek Nogal, Leigh M. Sewall, Alba Torrents de la Peña, Asma Rehman, Mimi Guebre-Xabier, Bethany Girard, Rituparna Das, Kizzmekia S. Corbett-Helaire, Robert A. Seder, Barney S. Graham, Darin K. Edwards, Nita Patel, Gale Smith, Andrew B. Ward |
| 5 |
[GO] |
2025―Jul―07 |
Broadly neutralizing antibodies targeting a conserved silent face of spike RBD resist extreme SARS-CoV-2 antigenic drift |
Ge Song, Meng Yuan, Hejun Liu, Tazio Capozzola, Ryan N. Lin, Jonathan L. Torres, Wan-ting He, Rami Musharrafieh, Katharina Dueker, Panpan Zhou, Sean Callaghan, Nitesh Mishra, Peter Yong, Fabio Anzanello, Gabriel Avillion, Anh Lina Vo, Xuduo Li, Yuexiu Zhang, Muzamil Makhdoomi, Ziqi Feng, Xueyong Zhu, Linghang Peng, David Nemazee, Yana Safonova, Bryan Briney, Andrew B. Ward, Dennis R. Burton, Ian A. Wilson, Raiees Andrabi |
| 6 |
[GO] |
2025―Jul―04 |
Structural and functional insights into the evolution of SARS-CoV-2 KP.3.1.1 spike protein |
Ziqi Feng, Jiachen Huang, Sabyasachi Baboo, Jolene K. Diedrich, Sandhya Bangaru, James C. Paulson, John R. Yates, Meng Yuan, Ian A. Wilson, Andrew B. Ward |
| 7 |
[GO] |
2025―Jul―04 |
A rare B cell clonotype imprinted by ancestral SARS-CoV-2 develops cross-sarbecovirus neutralization in immune recalls |
Xixian Chen, Ling Li, Ruiping Du, Zuowei Wang, Yunjian Li, Yi Sun, Rongrong Qin, Hualong Feng, Lin Hu, Xuanyi Chen, Maosheng Lu, Xueyan Huang, Haibo Wang, Liwei Jiang, Teng Zuo |
| 8 |
[GO] |
2025―Jul―02 |
Early innate immune response and evolution of a SARS-CoV-2 furin cleavage site inactive variant in bat cells |
Kaushal Baid, Sauhard Shrivastava, Jessica Luc, Daniel Richard, Jennifer A. Aguiar, Yoan Machado, Sophie-Marie Aicher, Kimberley C. Siwak, Emmanuelle V. LeBlanc, Zahed Khatooni, Kumari G. Lokugamage, Michelle N. Vu, Angelica Morgan, Arkadeb Bhuinya, Kim R. Chiok, Hai T. Nguyen, Hannah D. Stacey, Erin Scruten, Tracy Prysliak, Winfield Yim, Andrew G. McArthur, Matthew S. Miller, Heather L. Wilson, Terence Capellini, Paul A. Faure, Qiang Liu, Samira Mubareka, Vineet D. Menachery, Karen Mossman, Marcel A. Müller, Christian Drosten, Che C. Colpitts, Nolwenn Jouvenet, Christopher M. Overall, Andrew C. Doxey, Arinjay Banerjee |
| 9 |
[GO] |
2025―Jun―26 |
Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters |
Ricardo da Silva Antunes, Vicente Fajardo-Rosas, Esther Dawen Yu, Rosa Isela Gálvez, Adam Abawi, E. Alexandar Escarrega, Amparo Martínez-Pérez, Emil Johansson, Benjamin Goodwin, April Frazier, Jennifer M. Dan, Shane Crotty, Grégory Seumois, Daniela Weiskopf, Pandurangan Vijayanand, Alessandro Sette |
| 10 |
[GO] |
2025―Jun―25 |
Single-molecule imaging prefusion intermediate conformations of MERS-CoV spike trimers in membrane during entry |
Shuvankar Dey, Purba Pahari, Mridul Shukla, Raiees Andrabi, Dibyendu Kumar Das |
| 11 |
[GO] |
2025―Jun―19 |
The SARS-CoV-2 trigger highlights host interleukin 1 genetics in Epstein-Barr virus reactivation |
Petra Schneiderova, Jan Mizera, Arootin Gharibian, Gayane Manukyan, Milan Raska, Petr Gajdos, Petr Kosztyu, Samuel Genzor, Milos Kudelka, Milan Sova, Jakub Savara, Alena Borikova, Bishu Shrestha, Zuzana Mikulkova, Ladislav Stepanek, Jiri Kufa, Petr Jakubec, Eva Kriegova |
| 12 |
[GO] |
2025―Jun―19 |
Biological modifications of the immune response to COVID-19 vaccine in patients treated with rituximab and immune checkpoint inhibitors |
Francesco Ravera, Martina Dameri, Isabella Lombardo, Mario Stabile, Pamela Becherini, Neri Fallani, Camilla Scarsi, Benedetta Cigolini, Giusy Gentilcore, Alexander Domnich, Lodovica Zullo, Eugenia Cella, Giulia Francia, Eugenia Montanari, Andrea Orsi, Andrea Bellodi, Fabio Ferrando, Darawan Rinchai, Filippo Ballerini, Bianca Bruzzone, Damien Chaussabel, Jean-Charles Grivel, Carlo Genova, Roberto Massimo Lemoli, Davide Bedognetti, Alberto Ballestrero, Lorenzo Ferrando, Gabriele Zoppoli |
| 13 |
[GO] |
2025―Jun―03 |
Immune imprinting blunts omicron pathogenicity fluctuations and highlights the essential role of cellular immunity in SARS-CoV-2 infection |
Xiaohui Wei, Hekai Yang, Jing Wu, Binbin Zhao, Yameng Mu, Na Rong, Gengxin Zhang, Wanjun Peng, Lihong Zhang, Wei Zhang, Xiaoyue Ding, Gaoying Zhang, Zhihai Chen, Jiangning Liu |
| 14 |
[GO] |
2025―Mai―31 |
Designed miniproteins potently inhibit and protect against MERS-CoV |
Robert J. Ragotte, M. Alejandra Tortorici, Nicholas J. Catanzaro, Amin Addetia, Brian Coventry, Heather M. Froggatt, Jimin Lee, Cameron Stewart, Jack T. Brown, Inna Goreshnik, Jeremiah N. Sims, Lukas F. Milles, Basile I.M. Wicky, Matthias Glögl, Stacey Gerben, Alex Kang, Asim K. Bera, William Sharkey, Alexandra Schäfer, Jack R. Harkema, Ralph S. Baric, David Baker, David Veesler |
| 15 |
[GO] |
2025―Mai―12 |
SARS-CoV-2 nsp1 mediates broad inhibition of translation in mammals |
Risako Gen, Amin Addetia, Daniel Asarnow, Young-Jun Park, Joel Quispe, Matthew C. Chan, Jack T. Brown, Jimin Lee, Melody G. Campbell, Christopher P. Lapointe, David Veesler |
| 16 |
[GO] |
2025―Mai―09 |
Transfer of SARS-CoV-2 nucleocapsid protein to uninfected epithelial cells induces antibody-mediated complement deposition |
Jamal Fahoum, Maria Billan, Julia K. Varga, Dan Padawer, Yelena Britan-Rosich, Maya Elgrably-Weiss, Pallabi Basu, Miri Stolovich-Rain, Leah Baraz, Einav Cohen-Kfir, Sujata Kumari, Esther Oiknine-Djian, Manoj Kumar, Orly Zelig, Guy Mayer, Michail N. Isupov, Dana G. Wolf, Shoshy Altuvia, Reuven Wiener, Ora Schueler-Furman, Alexander Rouvinski |
| 17 |
[GO] |
2025―Apr―12 |
Phenotypic heterogeneity defines B cell responses to repeated SARS-CoV-2 exposures through vaccination and infection |
Lela Kardava, James Lim, Clarisa M. Buckner, Felipe Lopes de Assis, Xiaozhen Zhang, Wei Wang, Mattie L. Melnyk, Omar El Merhebi, Krittin Trihemasava, I-Ting Teng, Robin Carroll, Yogita Jethmalani, Mike Castro, Bob C. Lin, Lauren H. Praiss, Catherine A. Seamon, Peter D. Kwong, Richard A. Koup, Leonid Serebryannyy, David C. Nickle, Tae-Wook Chun, Susan Moir |
| 18 |
[GO] |
2025―Apr―11 |
Alveolar macrophages critically control infection by seasonal human coronavirus OC43 to avoid severe pneumonia |
Xuan Zhong, Tian Xie, Su-Yun Wang, Zhi-Sheng Xu, Xin-Xin Chi, Qiao-Shuai Lan, Bo-Wen Xie, Qin-Li Sun, Lei Yuan, Qiu-Yan Lan, Zi-Xuan Zhao, Bi-Rui Pan, Han Feng, Lu Lu, Yan-Yi Wang, Xiaohu Wang, Chen Dong |
| 19 |
[GO] |
2025―Apr―11 |
SIRT2 suppresses aging-associated cGAS activation and protects aged mice from severe COVID-19 |
Marine Barthez, Biyun Xue, Jian Zheng, Yifei Wang, Zehan Song, Wei-Chieh Mu, Chih-ling Wang, Jiayue Guo, Fanghan Yang, Yuze Ma, Xuetong Wei, Chengjin Ye, Nicholas Sims, Luis Martinez-Sobrido, Stanley Perlman, Danica Chen |
| 20 |
[GO] |
2025―Apr―08 |
Antibody evasiveness of SARS-CoV-2 subvariants KP.3.1.1 and XEC |
Qian Wang, Yicheng Guo, Ian A. Mellis, Madeline Wu, Hiroshi Mohri, Carmen Gherasim, Riccardo Valdez, Lawrence J. Purpura, Michael T. Yin, Aubree Gordon, David D. Ho |
| 21 |
[GO] |
2025―Apr―04 |
A global collaboration for systematic analysis of broad-ranging antibodies against the SARS-CoV-2 spike protein |
Sharon L. Schendel, Xiaoying Yu, Peter J. Halfmann, Jarjapu Mahita, Brendan Ha, Kathryn M. Hastie, Haoyang Li, Daniel Bedinger, Camille Troup, Kan Li, Natalia Kuzmina, Jordi B. Torrelles, Jennifer E. Munt, Melissa Maddocks, Mary Osei-Twum, Heather M. Callaway, Stephen Reece, Anne Palser, Paul Kellam, S. Moses Dennison, Richard H.C. Huntwork, Gillian Q. Horn, Milite Abraha, Elizabeth Feeney, Luis Martinez-Sobrido, Paula A. Pino, Amberlee Hicks, Chengjin Ye, Jun-Gyu Park, Billie Maingot, Sivakumar Periasamy, Michael Mallory, Trevor Scobey, Marie-Noelle Lepage, Natalie St-Amant, Sarwat Khan, Anaïs Gambiez, Ralph S. Baric, Alexander Bukreyev, Luc Gagnon, Timothy Germann, Yoshihiro Kawaoka, Georgia D. Tomaras, Bjoern Peters, Erica Ollmann Saphire |
| 22 |
[GO] |
2025―Apr―03 |
Long-lasting antibody B-cell responses to SARS-CoV-2 three years after the onset of the pandemic |
Luis M. Molinos-Albert, Rocío Rubio, Carla Martín-Pérez, Edwards Pradenas, Cèlia Torres, Alfons Jiménez, Mar Canyelles, Marta Vidal, Diana Barrios, Silvia Marfil, Ester Aparicio, Anna Ramírez-Morros, Benjamin Trinité, Josep Vidal-Alaball, Pere Santamaria, Pau Serra, Luis Izquierdo, Ruth Aguilar, Anna Ruiz-Comellas, Julià Blanco, Carlota Dobaño, Gemma Moncunill |
| 23 |
[GO] |
2025―Mrz―29 |
The impact of Coronavirus Nsp1 on host mRNA degradation is independent of its role in translation inhibition |
Emilie Bäumlin, Dominic Andenmatten, Jonas Luginbühl, Aurélien Lalou, Nino Schwaller, Evangelos D. Karousis |
| 24 |
[GO] |
2025―Jan―05 |
Nonhuman primate antigenic cartography of SARS-CoV-2 |
Annika Rössler, Antonia Netzl, Ninaad Lasrado, Jayeshbhai Chaudhari, Barbara Mühlemann, Samuel H. Wilks, Janine Kimpel, Derek J. Smith, Dan H. Barouch |
| 25 |
[GO] |
2024―Dez―20 |
Pressure to evade cell-autonomous innate sensing reveals interplay between mitophagy, IFN signaling, and SARS-CoV-2 evolution |
Jae Seung Lee, Mark Dittmar, Jesse Miller, Minghua Li, Kasirajan Ayyanathan, Max Ferretti, Jesse Hulahan, Kanupriya Whig, Zienab Etwebi, Trevor Griesman, David C. Schultz, Sara Cherry |
| 26 |
[GO] |
2024―Dez―12 |
SARS-CoV-2 3CLpro (main protease) regulates caspase activation of gasdermin-D/E pores leading to secretion and extracellular activity of 3CLpro |
Peter M. Grin, Kaushal Baid, Hugo C.R. de Jesus, Nedim Kozarac, Peter A. Bell, Steven Z. Jiang, Reinhild Kappelhoff, Georgina S. Butler, Nathan G.F. Leborgne, Christina Pan, Isabel Pablos, Yoan Machado, John C. Vederas, Hugh Kim, Charaf Benarafa, Arinjay Banerjee, Christopher M. Overall |
| 27 |
[GO] |
2024―Dez―06 |
Protein nanoparticle vaccines induce potent neutralizing antibody responses against MERS-CoV |
Cara W. Chao, Kaitlin R. Sprouse, Marcos C. Miranda, Nicholas J. Catanzaro, Miranda L. Hubbard, Amin Addetia, Cameron Stewart, Jack T. Brown, Annie Dosey, Adian Valdez, Rashmi Ravichandran, Grace G. Hendricks, Maggie Ahlrichs, Craig Dobbins, Alexis Hand, Jackson McGowan, Boston Simmons, Catherine Treichel, Isabelle Willoughby, Alexandra C. Walls, Andrew T. McGuire, Elizabeth M. Leaf, Ralph S. Baric, Alexandra Schäfer, David Veesler, Neil P. King |
| 28 |
[GO] |
2024―Nov―05 |
Uncovering cell-type-specific immunomodulatory variants and molecular phenotypes in COVID-19 using structurally resolved protein networks |
Prabal Chhibbar, Priyamvada Guha Roy, Munesh K. Harioudh, Daniel J. McGrail, Donghui Yang, Harinder Singh, Reinhard Hinterleitner, Yi-Nan Gong, S. Stephen Yi, Nidhi Sahni, Saumendra N. Sarkar, Jishnu Das |
| 29 |
[GO] |
2024―Nov―05 |
SARS-CoV-2 infection elucidates features of pregnancy-specific immunity |
Dong Sun Oh, Eunha Kim, Rachelly Normand, Guangqing Lu, Lydia L. Shook, Amanda Lyall, Olyvia Jasset, Stepan Demidkin, Emily Gilbert, Joon Kim, Babatunde Akinwunmi, Jessica Tantivit, Alice Tirard, Benjamin Y. Arnold, Kamil Slowikowski, Marcia B. Goldberg, Michael R. Filbin, Nir Hacohen, Long H. Nguyen, Andrew T. Chan, Xu G. Yu, Jonathan Z. Li, Lael Yonker, Alessio Fasano, Roy H. Perlis, Ofer Pasternak, Kathryn J. Gray, Gloria B. Choi, David A. Drew, Pritha Sen, Alexandra-Chloé Villani, Andrea G. Edlow, Jun R. Huh |
| 30 |
[GO] |
2024―Nov―05 |
An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivo |
Nian E. Zhou, Su Tang, Xuelin Bian, Maloy K. Parai, Inna V. Krieger, Armando Flores, Pradeep K. Jaiswal, Radha Bam, Jeremy L. Wood, Zhe Shi, Laura J. Stevens, Trevor Scobey, Meghan V. Diefenbacher, Fernando R. Moreira, Thomas J. Baric, Arjun Acharya, Joonyoung Shin, Manish M. Rathi, Karen C. Wolff, Laura Riva, Malina A. Bakowski, Case W. McNamara, Nicholas J. Catanzaro, Rachel L. Graham, David C. Schultz, Sara Cherry, Yoshihiro Kawaoka, Peter J. Halfmann, Ralph S. Baric, Mark R. Denison, Timothy P. Sheahan, James C. Sacchettini |
| 31 |
[GO] |
2024―Nov―05 |
Protective effect and molecular mechanisms of human non-neutralizing cross-reactive spike antibodies elicited by SARS-CoV-2 mRNA vaccination |
Jordan J. Clark, Irene Hoxie, Daniel C. Adelsberg, Iden A. Sapse, Robert Andreata-Santos, Jeremy S. Yong, Fatima Amanat, Johnstone Tcheou, Ariel Raskin, Gagandeep Singh, Irene González-Domínguez, Julia E. Edgar, Stylianos Bournazos, Weina Sun, Juan Manuel Carreño, Viviana Simon, Ali H. Ellebedy, Goran Bajic, Florian Krammer |
| 32 |
[GO] |
2024―Nov―01 |
TMEM106B-mediated SARS-CoV-2 infection allows for robust ACE2-independent infection in vitro but not in vivo |
Kexin Yan, Troy Dumenil, Romal Stewart, Cameron R. Bishop, Bing Tang, Wilson Nguyen, Andreas Suhrbier, Daniel J. Rawle |
| 33 |
[GO] |
2024―Nov―01 |
Serum proteome reveals distinctive molecular features of H7N9- and SARS-CoV-2-infected patients |
Yunzhi Wang, Zhigang Song, Peng Ran, Hang Xiang, Ziyan Xu, Ning Xu, Mengjie Deng, Lingli Zhu, Yanan Yin, Jinwen Feng, Chen Ding, Wenjun Yang |
| 34 |
[GO] |
2024―Okt―09 |
LPS-induced lung tissue-resident trained innate immunity provides differential protection against pneumococci and SARS-CoV-2 |
Alisha Kang, Gluke Ye, Sam Afkhami, Fatemah Aleithan, Kanwaldeep Singh, Anna Dvorkin-Gheva, Tobias Berg, Matthew S. Miller, Mangalakumari Jeyanathan, Zhou Xing |
| 35 |
[GO] |
2024―Aug―30 |
SARS-CoV-2 infection prior to vaccination amplifies Fc-mediated humoral profiles in an age-dependent manner |
Wonyeong Jung, Arturo Abdelnour, Paulina Kaplonek, Rolando Herrero, Jessica Shih-Lu Lee, Domenic R. Barbati, Taras M. Chicz, Kate S. Levine, Romain Clement Fantin, Viviana Loria, Carolina Porras, Douglas A. Lauffenburger, Mitchell H. Gail, Amada Aparicio, Allan Hildesheim, Galit Alter, Ryan P. McNamara |
| 36 |
[GO] |
2024―Aug―27 |
Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses |
Ida Paciello, Giulio Pierleoni, Elisa Pantano, Giada Antonelli, Piero Pileri, Giuseppe Maccari, Dario Cardamone, Giulia Realini, Federica Perrone, Martin Mayora Neto, Simone Pozzessere, Massimiliano Fabbiani, Francesca Panza, Ilaria Rancan, Mario Tumbarello, Francesca Montagnani, Duccio Medini, Piet Maes, Nigel Temperton, Etienne Simon-Loriere, Olivier Schwartz, Rino Rappuoli, Emanuele Andreano |
| 37 |
[GO] |
2024―Aug―03 |
Immunity against conserved epitopes dominates after two consecutive exposures to SARS-CoV-2 Omicron BA.1 |
Alexander Muik, Jasmin Quandt, Bonny Gaby Lui, Maren Bacher, Sebastian Lutz, Maika Grünenthal, Aras Toker, Jessica Grosser, Orkun Ozhelvaci, Olga Blokhina, Svetlana Shpyro, Isabel Vogler, Nadine Salisch, Özlem Türeci, Ugur Sahin |
| 38 |
[GO] |
2024―Jul―25 |
Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans |
Amin Addetia, Cameron Stewart, Albert J. Seo, Kaitlin R. Sprouse, Ayed Y. Asiri, Maha Al-Mozaini, Ziad A. Memish, Abeer N. Alshukairi, David Veesler |
| 39 |
[GO] |
2024―Jul―24 |
Cellular immune response to SARS-CoV-2 and clinical presentation in individuals exposed to endemic malaria |
Kesego Tapela, Diana Ahu Prah, Becky Tetteh, Franklin Nuokpem, Daniel Dosoo, Amin Coker, Frederick Kumi-Ansah, Emmanuella Amoako, Kissi Ohene Assah, Charlyne Kilba, Nancy Nyakoe, Darius Quansah, Sylvester Languon, Claudia Adzo Anyigba, Felix Ansah, Seth Agyeman, Irene Amoakoh Owusu, Kristan Schneider, William K. Ampofo, Joe Kimanthi Mutungi, Gloria Amegatcher, Yaw Aniweh, Gordon A. Awandare, Peter K. Quashie, Yaw Bediako |
| 40 |
[GO] |
2024―Jul―17 |
Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants |
Pei Li, Julia N. Faraone, Cheng Chih Hsu, Michelle Chamblee, Yi-Min Zheng, Claire Carlin, Joseph S. Bednash, Jeffrey C. Horowitz, Rama K. Mallampalli, Linda J. Saif, Eugene M. Oltz, Daniel Jones, Jianrong Li, Richard J. Gumina, Kai Xu, Shan-Lu Liu |
| 41 |
[GO] |
2024―Jul―05 |
Combining genomic data and infection estimates to characterize the complex dynamics of SARS-CoV-2 Omicron variants in the US |
Rafael Lopes, Kien Pham, Fayette Klaassen, Melanie H. Chitwood, Anne M. Hahn, Seth Redmond, Nicole A. Swartwood, Joshua A. Salomon, Nicolas A. Menzies, Ted Cohen, Nathan D. Grubaugh |
| 42 |
[GO] |
2024―Jun―18 |
Variant-specific antibody response following repeated SARS-CoV-2 vaccination and infection |
Xiao-Lin Jiang, Xue-Dong Song, Chao Shi, Guo-Jian Yang, Xue-Jun Wang, Yu-Wei Zhang, Jie Wu, Lian-Xiang Zhao, Ming-Zhu Zhang, Ming-Ming Wang, Rui-Rui Chen, Xue-Juan He, Er-Hei Dai, Hui-Xia Gao, Yuan Shen, Gang Dong, Yu-Ling Wang, Mai-Juan Ma |
| 43 |
[GO] |
2024―Jun―12 |
Single-cell-resolved interspecies comparison shows a shared inflammatory axis and a dominant neutrophil-endothelial program in severe COVID-19 |
Stefan Peidli, Geraldine Nouailles, Emanuel Wyler, Julia M. Adler, Sandra Kunder, Anne Voß, Julia Kazmierski, Fabian Pott, Peter Pennitz, Dylan Postmus, Luiz Gustavo Teixeira Alves, Christine Goffinet, Achim D. Gruber, Nils Blüthgen, Martin Witzenrath, Jakob Trimpert, Markus Landthaler, Samantha D. Praktiknjo |
| 44 |
[GO] |
2024―Jun―12 |
Deciphering a reliable synergistic bispecific strategy of rescuing antibodies for SARS-CoV-2 escape variants, including BA.2.86, EG.5.1, and JN.1 |
Zhou Tong, Jianyu Tong, Wenwen Lei, Yufeng Xie, Yingzi Cui, Guowen Jia, Shihua Li, Zezhong Zhang, Zhimin Cheng, Xiao Xing, Haiyun Ma, Lan Deng, Rong Zhang, Xin Zhao, Kefang Liu, Qihui Wang, Jianxun Qi, Haomin Huang, Rui Song, Zhaoming Su, Guizhen Wu, Jing Lou, George Fu Gao |
| 45 |
[GO] |
2024―Jun―05 |
Deep repertoire mining uncovers ultra-broad coronavirus neutralizing antibodies targeting multiple spike epitopes |
Jonathan Hurtado, Thomas F. Rogers, David B. Jaffe, Bruce A. Adams, Sandhya Bangaru, Elijah Garcia, Tazio Capozzola, Terrence Messmer, Pragati Sharma, Ge Song, Nathan Beutler, Wanting He, Katharina Dueker, Rami Musharrafieh, Sarah Burbach, Alina Truong, Michael J.T. Stubbington, Dennis R. Burton, Raiees Andrabi, Andrew B. Ward, Wyatt J. McDonnell, Bryan Briney |
| 46 |
[GO] |
2024―Mai―27 |
An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike |
Banghui Liu, Xuefeng Niu, Yijun Deng, Zhaoyong Zhang, Yanqun Wang, Xijie Gao, Huan Liang, Zimu Li, Qian Wang, Yuanyi Cheng, Qiuluan Chen, Shuangshuang Huang, Yingxian Pan, Mengzhen Su, Xiancheng Lin, Chuanying Niu, Yinglin Chen, Wenyi Yang, Yudi Zhang, Qihong Yan, Jun He, Jincun Zhao, Ling Chen, Xiaoli Xiong |
| 47 |
[GO] |
2024―Apr―10 |
SARS-CoV-2 variant of concern fitness and adaptation in primary human airway epithelia |
Rita M. Meganck, Caitlin E. Edwards, Michael L. Mallory, Rhianna E. Lee, Hong Dang, Alexis B. Bailey, Jason A. Wykoff, Samuel C. Gallant, Deanna R. Zhu, Boyd L. Yount, Takafumi Kato, Kendall M. Shaffer, Satoko Nakano, Anne Marie Cawley, Vishwaraj Sontake, Jeremy R. Wang, Robert S. Hagan, Melissa B. Miller, Purushothama Rao Tata, Scott H. Randell, Longping V. Tse, Camille Ehre, Kenichi Okuda, Richard C. Boucher, Ralph S. Baric |
| 48 |
[GO] |
2024―Mrz―15 |
Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication and pathogenicity |
Zemin Yang, Bryan A. Johnson, Victoria A. Meliopoulos, Xiaohui Ju, Peipei Zhang, Michael P. Hughes, Jinjun Wu, Kaitlin P. Koreski, Jemma E. Clary, Ti-Cheng Chang, Gang Wu, Jeff Hixon, Jay Duffner, Kathy Wong, Rene Lemieux, Kumari G. Lokugamage, R. Elias Alvarado, Patricia A. Crocquet-Valdes, David H. Walker, Kenneth S. Plante, Jessica A. Plante, Scott C. Weaver, Hong Joo Kim, Rachel Meyers, Stacey Schultz-Cherry, Qiang Ding, Vineet D. Menachery, J. Paul Taylor |
| 49 |
[GO] |
2024―Mrz―07 |
CD8+ T cell memory induced by successive SARS-CoV-2 mRNA vaccinations is characterized by shifts in clonal dominance |
Hiroyasu Aoki, Masahiro Kitabatake, Haruka Abe, Peng Xu, Mikiya Tsunoda, Shigeyuki Shichino, Atsushi Hara, Noriko Ouji-Sageshima, Chihiro Motozono, Toshihiro Ito, Kouji Matsushima, Satoshi Ueha |
| 50 |
[GO] |
2024―Feb―29 |
SARS-CoV-2 targets ribosomal RNA biogenesis |
V. Talya Yerlici, Audrey Astori, Nevraj S. Kejiou, Chris A. Jordan, Negin Khosraviani, Janet N.Y. Chan, Razqallah Hakem, Brian Raught, Alexander F. Palazzo, Karim Mekhail |
| 51 |
[GO] |
2024―Jan―30 |
Two-step evolution of HIV-1 budding system leading to pandemic in the human population |
Yoriyuki Konno, Keiya Uriu, Takayuki Chikata, Toru Takada, Jun-ichi Kurita, Mahoko Takahashi Ueda, Saiful Islam, Benjy Jek Yang Tan, Jumpei Ito, Hirofumi Aso, Ryuichi Kumata, Carolyn Williamson, Shingo Iwami, Masafumi Takiguchi, Yoshifumi Nishimura, Eiji Morita, Yorifumi Satou, So Nakagawa, Yoshio Koyanagi, Kei Sato |
| 52 |
[GO] |
2024―Jan―21 |
Deep spatial proteomics reveals region-specific features of severe COVID-19-related pulmonary injury |
Yiheng Mao, Ying Chen, Yuan Li, Longda Ma, Xi Wang, Qi Wang, An He, Xi Liu, Tianyi Dong, Weina Gao, Yanfen Xu, Liang Liu, Liang Ren, Qian Liu, Peng Zhou, Ben Hu, Yiwu Zhou, Ruijun Tian, Zheng-Li Shi |
| 53 |
[GO] |
2024―Jan―08 |
Ipsilateral immunization after a prior SARS-CoV-2 mRNA vaccination elicits superior B cell responses compared to contralateral immunization |
Wenxia Jiang, Alexander R. Maldeney, Xue Yuan, Martin J. Richer, Scott E. Renshaw, Wei Luo |
| 54 |
[GO] |
2023―Dez―20 |
The HLA-II immunopeptidome of SARS-CoV-2 |
Shira Weingarten-Gabbay, Da-Yuan Chen, Siranush Sarkizova, Hannah B. Taylor, Matteo Gentili, Gabrielle M. Hernandez, Leah R. Pearlman, Matthew R. Bauer, Charles M. Rice, Karl R. Clauser, Nir Hacohen, Steven A. Carr, Jennifer G. Abelin, Mohsan Saeed, Pardis C. Sabeti |
| 55 |
[GO] |
2023―Dez―15 |
Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivo |
Ryuta Uraki, Maki Kiso, Kiyoko Iwatsuki-Horimoto, Seiya Yamayoshi, Mutsumi Ito, Shiho Chiba, Yuko Sakai-Tagawa, Masaki Imai, Yukie Kashima, Michiko Koga, Noriko Fuwa, Nobumasa Okumura, Masayuki Hojo, Noriko Iwamoto, Hideaki Kato, Hideaki Nakajima, Norio Ohmagari, Hiroshi Yotsuyanagi, Yutaka Suzuki, Yoshihiro Kawaoka |
| 56 |
[GO] |
2023―Nov―21 |
Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53 |
Jonathan D. Lee, Bridget L. Menasche, Maria Mavrikaki, Madison M. Uyemura, Su Min Hong, Nina Kozlova, Jin Wei, Mia M. Alfajaro, Renata B. Filler, Arne Müller, Tanvi Saxena, Ryan R. Posey, Priscilla Cheung, Taru Muranen, Yujing J. Heng, Joao A. Paulo, Craig B. Wilen, Frank J. Slack |
| 57 |
[GO] |
2023―Nov―18 |
Evolution of the SARS-CoV-2 Omicron spike |
Ruth J. Parsons, Priyamvada Acharya |
| 58 |
[GO] |
2023―Okt―28 |
Beta-spike-containing boosters induce robust and functional antibody responses to SARS-CoV-2 in macaques primed with distinct vaccines |
Yixiang Deng, Caroline Atyeo, Dansu Yuan, Taras M. Chicz, Timothy Tibbitts, Matthew Gorman, Sabian Taylor, Valerie Lecouturier, Douglas A. Lauffenburger, Roman M. Chicz, Galit Alter, Ryan P. McNamara |
| 59 |
[GO] |
2023―Okt―23 |
Transgenic mouse models support a protective role of type I IFN response in SARS-CoV-2 infection-related lung immunopathology and neuroinvasion |
Nishant Ranjan Chauhan, Soumya Kundu, Ramyasingh Bal, Diya Chattopadhyay, Rinku Sahu, Subhash Mehto, Rina Yadav, Sivaram Krishna, Kautilya Kumar Jena, Sameekshya Satapathy, Anusha Pv, Krushna C. Murmu, Bharati Singh, Srinivas Patnaik, Sarita Jena, Krishnan H. Harshan, Gulam Hussain Syed, Mohammed M. Idris, Punit Prasad, Santosh Chauhan |
| 60 |
[GO] |
2023―Okt―04 |
Organ-specific immunity: A tissue analysis framework for investigating local immune responses to SARS-CoV-2 |
Alphonsus H.C. Ng, Huiqian Hu, Kai Wang, Kelsey Scherler, Sarah E. Warren, Daniel R. Zollinger, Jill McKay-Fleisch, Kristina Sorg, Joseph M. Beechem, Emily Ragaglia, J. Matthew Lacy, Kelly D. Smith, Desiree A. Marshall, Michael M. Bundesmann, Diego López de Castilla, David Corwin, Nicole Yarid, Beatrice S. Knudsen, Yue Lu, Jason D. Goldman, James R. Heath |
| 61 |
[GO] |
2023―Sep―19 |
Structural basis for translation inhibition by MERS-CoV Nsp1 reveals a conserved mechanism for betacoronaviruses |
Swapnil C. Devarkar, Michael Vetick, Shravani Balaji, Ivan B. Lomakin, Luojia Yang, Danni Jin, Wendy V. Gilbert, Sidi Chen, Yong Xiong |
| 62 |
[GO] |
2023―Sep―13 |
Light chain of a public SARS-CoV-2 class-3 antibody modulates neutralization against Omicron |
Anamika Patel, Sanjeev Kumar, Lilin Lai, Meredith Keen, Rajesh Valanparambil, Chennareddy Chakravarthy, Zane Laughlin, Filipp Frank, Narayanaiah Cheedarla, Hans P. Verkerke, Andrew S. Neish, John D. Roback, Carl W. Davis, Jens Wrammert, Amit Sharma, Rafi Ahmed, Mehul S. Suthar, Kaja Murali-Krishna, Anmol Chandele, Eric Ortlund |
| 63 |
[GO] |
2023―Sep―06 |
SARS-CoV-2 variants with NSP12 P323L/G671S mutations display enhanced virus replication in ferret upper airways and higher transmissibility |
Se-Mi Kim, Eun-Ha Kim, Mark Anthony B. Casel, Young-Il Kim, Rong Sun, Mi-Jeong Kwak, Ji-Seung Yoo, Mina Yu, Kwang-Min Yu, Seung-Gyu Jang, Rare Rollon, Jeong Ho Choi, Juryeon Gil, Kiyoung Eun, Hyunggee Kim, Armin Ensser, Jungwon Hwang, Min-Suk Song, Myung Hee Kim, Jae U. Jung, Young Ki Choi |
| 64 |
[GO] |
2023―Aug―16 |
Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly |
Isabella A.T.M. Ferreira, Colin Y.C. Lee, William S. Foster, Adam Abdullahi, Lisa M. Dratva, Zewen Kelvin Tuong, Benjamin J. Stewart, John R. Ferdinand, Stephane M. Guillaume, Martin O.P. Potts, Marianne Perera, Benjamin A. Krishna, Ana Peñalver, Mia Cabantous, Steven A. Kemp, Lourdes Ceron-Gutierrez, Soraya Ebrahimi, Paul Lyons, Kenneth G.C. Smith, John Bradley, Dami A. Collier, Laura E. McCoy, Agatha van der Klaauw, James E.D. Thaventhiran, I. Sadaf Farooqi, Sarah A. Teichmann, Paul A. MacAry, Rainer Doffinger, Mark R. Wills, Michelle A. Linterman, Menna R. Clatworthy, Ravindra K. Gupta |
| 65 |
[GO] |
2023―Aug―14 |
Genome-wide CRISPR screens identify noncanonical translation factor eIF2A as an enhancer of SARS-CoV-2 programmed -1 ribosomal frameshifting |
Lian-Huan Wei, Yu Sun, Junjie U. Guo |
| 66 |
[GO] |
2023―Jul―21 |
A comprehensive Drosophila resource to identify key functional interactions between SARS-CoV-2 factors and host proteins |
Annabel Guichard, Shenzhao Lu, Oguz Kanca, Daniel Bressan, Yan Huang, Mengqi Ma, Sara Sanz Juste, Jonathan C. Andrews, Kristy L. Jay, Marketta Sneider, Ruth Schwartz, Mei-Chu Huang, Danqing Bei, Hongling Pan, Liwen Ma, Wen-Wen Lin, Ankush Auradkar, Pranjali Bhagwat, Soo Park, Kenneth H. Wan, Takashi Ohsako, Toshiyuki Takano-Shimizu, Susan E. Celniker, Michael F. Wangler, Shinya Yamamoto, Hugo J. Bellen, Ethan Bier |
| 67 |
[GO] |
2023―Jul―20 |
Super-resolution proximity labeling reveals anti-viral protein network and its structural changes against SARS-CoV-2 viral proteins |
Yun-Bin Lee, Minkyo Jung, Jeesoo Kim, Afandi Charles, Wanda Christ, Jiwoong Kang, Myeong-Gyun Kang, Chulhwan Kwak, Jonas Klingström, Anna Smed-Sörensen, Jong-Seo Kim, Ji Young Mun, Hyun-Woo Rhee |
| 68 |
[GO] |
2023―Jul―19 |
Structural definition of HLA class II-presented SARS-CoV-2 epitopes reveals a mechanism to escape pre-existing CD4+ T cell immunity |
Yuan Chen, Georgina H. Mason, D. Oliver Scourfield, Alexander Greenshields-Watson, Tracey A. Haigh, Andrew K. Sewell, Heather M. Long, Awen M. Gallimore, Pierre Rizkallah, Bruce J. MacLachlan, Andrew Godkin |
| 69 |
[GO] |
2023―Jul―12 |
Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccine |
Felipe Lopes de Assis, Kenneth B. Hoehn, Xiaozhen Zhang, Lela Kardava, Connor D. Smith, Omar El Merhebi, Clarisa M. Buckner, Krittin Trihemasava, Wei Wang, Catherine A. Seamon, Vicky Chen, Paul Schaughency, Foo Cheung, Andrew J. Martins, Chi-I Chiang, Yuxing Li, John S. Tsang, Tae-Wook Chun, Steven H. Kleinstein, Susan Moir |
| 70 |
[GO] |
2023―Mai―30 |
Extrafollicular IgD-CD27-CXCR5-CD11c- DN3 B cells infiltrate inflamed tissues in autoimmune fibrosis and in severe COVID-19 |
Hugues Allard-Chamard, Naoki Kaneko, Alice Bertocchi, Na Sun, Julie Boucau, Hsiao-Hsuan Kuo, Jocelyn R. Farmer, Cory Perugino, Vinay S. Mahajan, Samuel J.H. Murphy, Katherine Premo, Thomas Diefenbach, Musie Ghebremichael, Grace Yuen, Alekhya Kotta, Zafer Akman, Mathias Lichterfeld, Bruce D. Walker, Xu G. Yu, Masafumi Moriyama, Takashi Maehara, Seiji Nakamura, John H. Stone, Robert F. Padera, Shiv Pillai |
| 71 |
[GO] |
2023―Mai―29 |
Proteomic analysis of circulating immune cells identifies cellular phenotypes associated with COVID-19 severity |
Martin Potts, Alice Fletcher-Etherington, Katie Nightingale, Federica Mescia, Laura Bergamaschi, Fernando J. Calero-Nieto, Robin Antrobus, James Williamson, Harriet Parsons, Edward L. Huttlin, Nathalie Kingston, Berthold Göttgens, John R. Bradley, Paul J. Lehner, Nicholas J. Matheson, Kenneth G.C. Smith, Mark R. Wills, Paul A. Lyons, Michael P. Weekes |
| 72 |
[GO] |
2023―Mai―26 |
Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktail |
Amin Addetia, Young-Jun Park, Tyler Starr, Allison J. Greaney, Kaitlin R. Sprouse, John E. Bowen, Sasha W. Tiles, Wesley C. Van Voorhis, Jesse D. Bloom, Davide Corti, Alexandra C. Walls, David Veesler |
| 73 |
[GO] |
2023―Mai―03 |
Fortuitous Somatic Mutations during Antibody Evolution Endow Broad Neutralization against SARS-CoV-2 Omicron Variants |
Jianbo Wu, Zhenguo Chen, Yidan Gao, Zegen Wang, Jiarong Wang, Bing-Yu Chiang, Yunjiao Zhou, Yuru Han, Wuqiang Zhan, Minxiang Xie, Weiyu Jiang, Xiang Zhang, Aihua Hao, Anqi Xia, Jiaying He, Song Xue, Christian T. Mayer, Fan Wu, Bin Wang, Lunan Zhang, Lei Sun, Qiao Wang |
| 74 |
[GO] |
2023―Apr―21 |
Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccination |
Zixi Yin, Ji-Li Chen, Yongxu Lu, Beibei Wang, Leila Godfrey, Alexander J. Mentzer, Xuan Yao, Guihai Liu, Dannielle Wellington, Yiqi Zhao, Peter A.C. Wing, Wanwisa Dejnirattisa, Piyada Supasa, Chang Liu, Philip Hublitz, Ryan Beveridge, Craig Waugh, Sally-Ann Clark, Kevin Clark, Paul Sopp, Timothy Rostron, Juthathip Mongkolsapaya, Gavin R. Screaton, Graham Ogg, Katie Ewer, Andrew J. Pollard, Sarah Gilbert, Julian C. Knight, Teresa Lambe, Geoffrey L. Smith, Tao Dong, Yanchun Peng |
| 75 |
[GO] |
2023―Apr―04 |
Vaccination provides superior in vivo recall capacity of SARS-CoV-2 specific memory CD8 T cells |
Inga Kavazović, Christoforos Dimitropoulos, Dora Gašparini, Mari Rončević Filipović, Igor Barković, Jan Koster, Niels A. Lemmermann, Marina Babič, Đurđica Cekinović Grbeša, Felix M. Wensveen |
| 76 |
[GO] |
2023―Apr―03 |
Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses |
Audrey Kassardjian, Eric Sun, Jamie Sookhoo, Krithika Muthuraman, Kayluz Frias Boligan, Iga Kucharska, Edurne Rujas, Arif Jetha, Donald R. Branch, Shawn Babiuk, Brian Barber, Jean-Philippe Julien |
| 77 |
[GO] |
2023―Mrz―15 |
The changing health impact of vaccines in the COVID-19 pandemic: a modeling study |
Jamie A. Cohen, Robyn M. Stuart, Jasmina Panovska-Griffiths, Edinah Mudimu, Romesh G. Abeysuriya, Cliff C. Kerr, Michael Famulare, Daniel J. Klein |
| 78 |
[GO] |
2023―Mrz―15 |
The diversity of the glycan shield of sarbecoviruses related to SARS-CoV-2 |
Joel D. Allen, Dylan Ivory, Sophie Ge Song, Wan-ting He, Tazio Capozzola, Peter Yong, Dennis R. Burton, Raiees Andrabi, Max Crispin |
| 79 |
[GO] |
2023―Mrz―10 |
Coronavirus Subverts ER-phagy by Hijacking FAM134B and ATL3 into p62 Condensates to Facilitate Viral Replication |
Xuan Tan, Kun Cai, Jiajia Li, Zhen Yuan, Ruifeng Chen, Hurong Xiao, Chuanrui Xu, Bing Hu, Yali Qin, Binbin Ding |
| 80 |
[GO] |
2023―Mrz―09 |
Identification of the viral and cellular microRNA interactomes during SARS-CoV-2 infection |
Nicolas Fossat, Emma A. Lundsgaard, Rui Costa, Lizandro R. Rivera-Rangel, Louise Nielsen, Lotte S. Mikkelsen, Santseharay Ramirez, Jens Bukh, Troels K.H. Scheel |
| 81 |
[GO] |
2023―Mrz―07 |
Rapid escape of new SARS-CoV-2 Omicron variants from BA.2 directed antibody responses. |
Aiste Dijokaite-Guraliuc, Raksha Das, Daming Zhou, Helen M. Ginn, Chang Liu, Helen M.E. Duyvesteyn, Jiandong Huo, Rungtiwa Nutalai, Piyada Supasa, Muneeswaran Selvaraj, Thushan I. de Silva, Megan Plowright, Thomas A.H. Newman, Hailey Hornsby, Alexander J. Mentzer, Donal Skelly, Thomas G. Ritter, Nigel Temperton, Paul Klenerman, Eleanor Barnes, Susanna J. Dunachie, Cornelius Roemer, Thomas P. Peacock, Neil G. Paterson, Mark A. Williams, David R. Hall, Elizabeth E. Fry, Juthathip Mongkolsapaya, Jingshan Ren, David I. Stuart, Gavin R. Screaton |
| 82 |
[GO] |
2023―Mrz―06 |
Antigen presentation dynamics shape the response to emergent variants like SARS-CoV-2 Omicron strain after multiple vaccinations with wild type strain |
Leerang Yang, Matthew Van Beek, Zijun Wang, Frauke Muecksch, Marie Canis, Theodora Hatziioannou, Paul D. Bieniasz, Michel C. Nussenzweig, Arup K. Chakraborty |
| 83 |
[GO] |
2023―Mrz―06 |
Design of a stabilized RBD enables potently neutralizing SARS-CoV-2 single-component nanoparticle vaccines |
Thayne H. Dickey, Rui Ma, Sachy Orr-Gonzalez, Tarik Ouahes, Palak Patel, Holly McAleese, Brandi Butler, Elizabeth Eudy, Brett Eaton, Michael Murphy, Jennifer L. Kwan, Nichole D. Salinas, Michael R. Holbrook, Lynn E. Lambert, Niraj H. Tolia |
| 84 |
[GO] |
2023―Feb―17 |
SARS-CoV-2 spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID syndrome in mice |
Fabricia L. Fontes-Dantas, Gabriel G. Fernandes, Elisa G. Gutman, Emanuelle V. De Lima, Leticia S. Antonio, Mariana B. Hammerle, Hannah P. Mota-Araujo, Lilian C. Colodeti, Suzana M.B. Araújo, Gabrielle M. Froz, Talita N. da Silva, Larissa A. Duarte, Andreza L. Salvio, Karina L. Pires, Luciane A.A. Leon, Claudia Cristina F. Vasconcelos, Luciana Romão, Luiz Eduardo B. Savio, Jerson L. Silva, Robson da Costa, Julia R. Clarke, Andrea T. Da Poian, Soniza V. Alves-Leon, Giselle F. Passos, Claudia P. Figueiredo |
| 85 |
[GO] |
2023―Jan―30 |
CRISPR screening reveals a requirement for ribosome recycling in efficient SARS-CoV-2 programmed ribosomal frameshifting and viral replication |
Frederick Rehfeld, Jennifer L. Eitson, Maikke B. Ohlson, Tsung-Cheng Chang, John W. Schoggins, Joshua T. Mendell |
| 86 |
[GO] |
2023―Jan―17 |
Ablation of Adar1 in myeloid cells imprints a global antiviral state in the lung and heightens early immunity against SARS-CoV-2 |
Julia Z. Adamska, Rohit Verma, Shakti Gupta, Thomas Hagan, Florian Wimmers, Katherine Floyd, Qin Li, Erika V. Valore, Yanli Wang, Meera Trisal, José G. Vilches-Moure, Shankar Subramaniam, Carl R. Walkley, Mehul S. Suthar, Jin Billy Li, Bali Pulendran |
| 87 |
[GO] |
2023―Jan―09 |
SARS-CoV-2 Omicron subvariants Spike recognition and neutralization elicited after the third dose of mRNA vaccine |
Alexandra Tauzin, Alexandre Nicolas, Shilei Ding, Mehdi Benlarbi, Halima Medjahed, Debashree Chatterjee, Katrina Dionne, Shang Yu Gong, Gabrielle Gendron-Lepage, Yuxia Bo, Josée Perreault, Guillaume Goyette, Laurie Gokool, Pascale Arlotto, Chantal Morrisseau, Cécile Tremblay, Valérie Martel-Laferrière, Gaston De Serres, Inès Levade, Daniel E. Kaufmann, Marceline Côté, Renée Bazin, Andrés Finzi |
| 88 |
[GO] |
2023―Jan―09 |
Prevalent and immunodominant CD8 T-cell epitopes are conserved in SARS-CoV-2 variants |
Saskia Meyer, Isaac Blaas, Ravi Chand Bollineni, Marina Delic-Sarac, Trung T. Tran, Cathrine Knetter, Ke-Zheng Dai, Torfinn Støve Madssen, John T. Vaage, Alice Gustavsen, Weiwen Yang, Lise Sofie Haug Nissen-Meyer, Karolos Douvlataniotis, Maarja Laos, Morten Milek Nielsen, Bernd Thiede, Arne Søraas, Fridtjof Lund-Johansen, Even H. Rustad, Johanna Olweus |
| 89 |
[GO] |
2022―Dez―26 |
Liquid-Liquid phase separation of nucleocapsid proteins during SARS-CoV-2 and HIV-1 replication |
Bao-An Chau, Venessa Chen, Alan W. Cochrane, Leslie J. Parent, Andrew J. Mouland |
| 90 |
[GO] |
2022―Dez―12 |
SARS-CoV-2 escapes direct NK cell killing through Nsp1-mediated downregulation of ligands for NKG2D |
Madeline J. Lee, Michelle W. Leong, Arjun Rustagi, Aimee Beck, Leiping Zeng, Susan Holmes, Lei S. Qi, Catherine A. Blish |
| 91 |
[GO] |
2022―Nov―29 |
Cross-reaction of current available SARS-CoV-2 MAbs against the pangolin-origin coronavirus GX/P2V/2017 |
Yunfei Jia, Sheng Niu, Yu Hu, Yan Chai, Anqi Zheng, Chao Su, Lili Wu, Pengcheng Han, Pu Han, Dan Lu, Zhimin Liu, Xinxin Yan, Di Tian, Zhihai Chen, Jianxun Qi, Wen-xia Tian, Qihui Wang, George Fu Gao |
| 92 |
[GO] |
2022―Nov―22 |
Bulk IgG Glycosylation Predicts COVID-19 Severity and Vaccine Antibody Response |
Michelle K. Ash, Pavan P. Bhimalli, Byoung-Kyu Cho, Basil Baby Mattamana, Stéphanie Gambut, Imad Tarhoni, Cristina L. Fhied, Anjelica F. Reyes, Samantha J. Welninski, Jaison Arivalagan, Fernanda Negrão, Renu Goel, Todd L. Beck, Thomas J. Hope, Beverly E. Sha, Young Ah Goo, Lena Al-Harthi, João I. Mamede, Jeffrey A. Borgia, Neil L. Kelleher, Jeffrey R. Schneider |
| 93 |
[GO] |
2022―Nov―10 |
Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of the original mRNA vaccine |
Xuping Xie, Jing Zou, Chaitanya Kurhade, Mingru Liu, Ping Ren, Pei-Yong Shi |
| 94 |
[GO] |
2022―Nov―07 |
Shared genetic influences between blood analyte levels and risk of severe COVID-19 |
Hamzeh M. Tanha, Anita Sathyanarayanan, Divya Mehta, Dale R. Nyholt |
| 95 |
[GO] |
2022―Okt―27 |
Molecular analysis of a public cross-neutralizing antibody response to SARS-CoV-2 |
Meng Yuan, Yiquan Wang, Huibin Lv, Timothy J.C. Tan, Ian A. Wilson, Nicholas C. Wu |
| 96 |
[GO] |
2022―Okt―18 |
SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations |
Elizabeth M. Anderson, Shuk Hang Li, Moses Awofolaju, Theresa Eilola, Eileen Goodwin, Marcus J. Bolton, Sigrid Gouma, Tomaz B. Manzoni, Philip Hicks, Rishi R. Goel, Mark M. Painter, Sokratis A. Apostolidis, Divij Mathew, Debora Dunbar, Danielle Fiore, Amanda Brock, JoEllen Weaver, John S. Millar, Stephanie DerOhannessian, Allison R. Greenplate, Ian Frank, Daniel J. Rader, E. John Wherry, Paul Bates, Scott E. Hensley |
| 97 |
[GO] |
2022―Okt―12 |
SARS-CoV-2 infects neurons and induces neuroinflammation in a non-human primate model of COVID-19 |
Danielle Beckman, Alyssa Bonillas, Giovanne B. Diniz, Sean Ott, Jamin W. Roh, Sonny R. Elizaldi, Brian A. Schmidt, Rebecca L. Sammak, Koen K.A. Van Rompay, Smita S. Iyer, John H. Morrison |
| 98 |
[GO] |
2022―Okt―05 |
ZBTB7A promotes virus-host homeostasis during human coronavirus 229E infection |
Xinyu Zhu, Joseph D. Trimarco, Courtney A. Williams, Alejandro Barrera, Timothy E. Reddy, Nicholas S. Heaton |
| 99 |
[GO] |
2022―Okt―05 |
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two doses |
Alexandra Tauzin, Shang Yu Gong, Debashree Chatterjee, Shilei Ding, Mark M. Painter, Rishi R. Goel, Guillaume Beaudoin-Bussières, Lorie Marchitto, Marianne Boutin, Annemarie Laumaea, James Okeny, Gabrielle Gendron-Lepage, Catherine Bourassa, Halima Medjahed, Guillaume Goyette, Justine C. Williams, Yuxia Bo, Laurie Gokool, Chantal Morrisseau, Pascale Arlotto, Renée Bazin, Judith Fafard, Cécile Tremblay, Daniel E. Kaufmann, Gaston De Serres, Jonathan Richard, Marceline Côté, Ralf Duerr, Valérie Martel-Laferrière, Allison R. Greenplate, E. John Wherry, Andrés Finzi |
| 100 |
[GO] |
2022―Okt―05 |
BNT162b2 induced neutralizing and non-neutralizing antibody functions against SARS-CoV-2 diminish with age |
Timothy A. Bates, Pei Lu, Ye jin Kang, Devin Schoen, Micah Thornton, Savannah K. McBride, Chanhee Park, Daehwan Kim, William B. Messer, Marcel E. Curlin, Fikadu G. Tafesse, Lenette L. Lu |
| 101 |
[GO] |
2022―Sep―30 |
Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants |
Zhaochun Chen, Peng Zhang, Yumiko Matsuoka, Yaroslav Tsybovsky, Kamille West, Celia Santos, Lisa F. Boyd, Hanh Nguyen, Anna Pomerenke, Tyler Stephens, Adam S. Olia, Baoshan Zhang, Valeria De Giorgi, Michael R. Holbrook, Robin Gross, Elena Postnikova, Nicole L. Garza, Reed F. Johnson, David H. Margulies, Peter D. Kwong, Harvey J. Alter, Ursula J. Buchholz, Paolo Lusso, Patrizia Farci |
| 102 |
[GO] |
2022―Aug―29 |
Spike Protein-independent Attenuation of SARS-CoV-2 Omicron Variant in Laboratory Mice |
Shufeng Liu, Prabhuanand Selvaraj, Kotou Sangare, Binquan Luan, Tony T. Wang |
| 103 |
[GO] |
2022―Aug―23 |
A key F27I substitution within HCDR1 facilitates the rapid maturation of P2C-1F11-like neutralizing antibodies in a SARS-CoV-2-infected donor |
Miao Wang, Qing Fan, Bing Zhou, Haocheng Ye, Senlin Shen, Jiazhen Yu, Lin Cheng, Xiangyang Ge, Bin Ju, Zheng Zhang |
| 104 |
[GO] |
2022―Aug―15 |
N1-methylpseudouridine found within COVID-19 mRNA vaccines produces faithful protein products |
Kyusik Q. Kim, Bhagyashri D. Burgute, Shin-Cheng Tzeng, Crystal Jing, Courtney Jungers, Junya Zhang, Liewei L. Yan, Richard D. Vierstra, Sergej Djuranovic, Bradley S. Evans, Hani S. Zaher |
| 105 |
[GO] |
2022―Aug―15 |
Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice |
Alexandra C. Walls, Laura A. VanBlargan, Kai Wu, Angela Choi, Mary Jane Navarro, Diana Lee, Laura Avena, Daniela Montes Berrueta, Minh N. Pham, Sayda Elbashir, John C. Kraft, Marcos C. Miranda, Elizabeth Kepl, Max Johnson, Alyssa Blackstone, Kaitlin Sprouse, Brooke Fiala, Megan A. O’Connor, Natalie Brunette, Prabhu S. Arunachalam, Lisa Shirreff, Kenneth Rogers, Lauren Carter, Deborah H. Fuller, Francois Villinger, Bali Pulendran, Michael S. Diamond, Darin K. Edwards, Neil P. King, David Veesler |
| 106 |
[GO] |
2022―Aug―12 |
SARS-CoV-2 Vaccine-Induced Antibody and T-Cell Response in SARS-CoV-1 Survivors |
Li-Jun Duan, Xiao-Ming Cui, Ka-Li Zhu, Lin Yao, Guo-Lin Wang, Wu-Chun Cao, Mai-Juan Ma |
| 107 |
[GO] |
2022―Aug―11 |
A neutralizing epitope on the SD1 domain of SARS-CoV-2 Spike targeted following infection and vaccination. |
Jeffrey Seow, Hataf Khan, Annachiara Rosa, Valeria Calvaresi, Carl Graham, Suzanne Pickering, Valerie E. Pye, Nora B. Cronin, Isabella Huettner, Michael H. Malim, Argyris Politis, Peter Cherepanov, Katie J. Doores |
| 108 |
[GO] |
2022―Aug―03 |
SARS-CoV-2 Spike N-Terminal Domain modulates TMPRSS2-dependent viral entry and fusogenicity |
Bo Meng, Rawlings Datir, Jinwook Choi, John R. Bradley, Kenneth GC. Smith, Joo Hyeon Lee, Ravindra K. Gupta |
| 109 |
[GO] |
2022―Aug―03 |
Vaccine-associated enhanced respiratory pathology in COVID-19 hamsters after TH2-biased immunization |
Aileen Ebenig, Samada Muraleedharan, Julia Kazmierski, Daniel Todt, Arne Auste, Martina Anzaghe, André Gömer, Dylan Postmus, Patricia Gogesch, Marc Niles, Roland Plesker, Csaba Miskey, Michelle Gellhorn Serra, Angele Breithaupt, Cindy Hörner, Carina Kruip, Rosina Ehmann, Zoltan Ivics, Zoe Waibler, Stephanie Pfaender, Emanuel Wyler, Markus Landthaler, Alexandra Kupke, Geraldine Nouailles, Christine Goffinet, Richard J.P. Brown, Michael D. Mühlebach |
| 110 |
[GO] |
2022―Jul―19 |
Multiplexed LNP-mRNA vaccination against pathogenic coronavirus species |
Lei Peng, Zhenhao Fang, Paul A. Renauer, Andrew McNamara, Jonathan J. Park, Qianqian Lin, Xiaoyu Zhou, Matthew B. Dong, Biqing Zhu, Hongyu Zhao, Craig B. Wilen, Sidi Chen |
| 111 |
[GO] |
2022―Jul―14 |
Plasmacytoid Dendritic Cells during COVID-19: ally or adversary? |
Renée Marije van der Sluis, Christian Kanstrup Holm, Martin Roelsgaard Jakobsen |
| 112 |
[GO] |
2022―Jul―04 |
Amelioration of SARS-CoV-2 infection by ANO6 phospholipid scramblase inhibition |
Ju-Ri Sim, Dong Hoon Shin, Pil-Gu Park, So-Hyeon Park, Joon-Yong Bae, Youngchae Lee, Dha-Yei Kang, Ye Jin Kim, Sowon Aum, Shin Hye Noh, Su Jin Hwang, Hye-Ran Cha, Cheong Bi Kim, Si Hwan Ko, Sunghoon Park, Dongkyu Jeon, Sungwoo Cho, Gee Eun Lee, Jeonghun Kim, Young-hye Moon, Jae-Ouk Kim, Jae-Sung Nam, Chang-Hoon Kim, Sungmin Moon, Youn Wook Chung, Man-Seong Park, Ji-Hwan Ryu, Wan Namkung, Jae Myun Lee, Min Goo Lee |
| 113 |
[GO] |
2022―Jun―27 |
Viral E Protein Neutralizes BET Protein-Mediated Post-Entry Antagonism of SARS-CoV-2 |
Irene P. Chen, James E. Longbotham, Sarah McMahon, Rahul K. Suryawanshi, Mir M. Khalid, Taha Y. Taha, Takako Tabata, Jennifer M. Hayashi, Frank W. Soveg, Jared Carlson-Stevermer, Meghna Gupta, Meng Yao Zhang, Victor L. Lam, Yang Li, Zanlin Yu, Erron W. Titus, Amy Diallo, Jennifer Oki, Kevin Holden, Nevan Krogan, Danica Galonić Fujimori, Melanie Ott |
| 114 |
[GO] |
2022―Jun―21 |
Longitudinal analyses reveal distinct immune response landscapes in lung and intestinal tissues from SARS-CoV-2-infected rhesus macaques |
Huiwen Zheng, Yanli Chen, Jing Li, Heng Li, Xin Zhao, Jiali Li, Fengmei Yang, Yanyan Li, Changkun Liu, Li Qin, Yuanyuan Zuo, Qian Zhang, Zhanlong He, Haijing Shi, Qihan Li, Longding Liu |
| 115 |
[GO] |
2022―Jun―14 |
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues |
Matteo D’Antonio, Jennifer P. Nguyen, Timothy D. Arthur, Hiroko Matsui, Agnieszka D’Antonio-Chronowska, Kelly A. Frazer |
| 116 |
[GO] |
2022―Jun―13 |
Antibodies targeting conserved non-canonical antigens and endemic coronaviruses associate with favorable outcomes in severe COVID-19 |
Sai Preetham Peddireddy, Syed A. Rahman, Anthony R. Cillo, Godhev Manakkat Vijay, Ashwin Somasundaram, Creg J. Workman, William Bain, Bryan J. McVerry, Barbara Methe, Janet S. Lee, Prabir Ray, Anuradha Ray, Tullia C. Bruno, Dario A.A. Vignali, Georgios D. Kitsios, Alison Morris, Harinder Singh, Aniruddh Sarkar, Jishnu Das |
| 117 |
[GO] |
2022―Jun―13 |
COVID-19 vaccination elicits an evolving, cross-reactive antibody response to epitopes conserved with endemic coronavirus Spike proteins |
Evan A. Elko, Georgia A. Nelson, Heather L. Mead, Erin J. Kelley, Sophia T. Carvalho, Nathan G. Sarbo, Caroline E. Harms, Virginia Le Verche, Angelo A. Cardoso, Jennifer L. Ely, Annalee S. Boyle, Alejandra Piña, Sierra N. Henson, Fatima Rahee, Paul S. Keim, Kimberly R. Celona, Jinhee Yi, Erik W. Settles, Daniela A. Bota, George C. Yu, Sheldon R. Morris, John A. Zaia, Jason T. Ladner, John A. Altin |
| 118 |
[GO] |
2022―Jun―09 |
A diminished immune response underlies age-related SARS-CoV-2 pathologies |
Kohei Oishi, Shu Horiuchi, Justin Frere, Robert E. Schwartz, Benjamin R. tenOever |
| 119 |
[GO] |
2022―Jun―08 |
Cryo-EM structures of SARS-CoV-2 Omicron BA.2 spike |
Victoria Stalls, Jared Lindenberger, Sophie M.-C. Gobeil, Rory Henderson, Rob Parks, Maggie Barr, Margaret Deyton, Mitchell Martin, Katarzyna Janowska, Xiao Huang, Aaron May, Micah Speakman, Esther Beaudoin, Bryan Kraft, Xiaozhi Lu, Robert J. Edwards, Amanda Eaton, David C. Montefiori, Wilton B. Williams, Kevin O. Saunders, Kevin Wiehe, Barton F. Haynes, Priyamvada Acharya |
| 120 |
[GO] |
2022―Mai―30 |
Emerging viruses: Cross-species transmission of Coronaviruses, Filoviruses, Henipaviruses and Rotaviruses from bats |
Jin Tian, Jiumeng Sun, Dongyan Li, Ningning Wang, Lifang Wang, Chang Zhang, Xiaorong Meng, Xiang Ji, Marc A. Suchard, Xu Zhang, Alexander Lai, Shuo Su, Michael Veit |
| 121 |
[GO] |
2022―Mai―27 |
Spatial region-resolved proteome map reveals mechanism of COVID-19-associated heart injury |
Ling Leng, Jie Ma, Pei-Pei Zhang, Si-Chi Xu, Xiao Li, Ye Jin, Jun Cai, Rui Tang, Lei Zhao, Zhi-Cheng He, Man-Sheng Li, Hui Zhang, Liang-Rui Zhou, Zhi-Hong Wu, Tian-Ran Li, Yun-Ping Zhu, Yu-Jie Wang, Hai-Bo Wu, Yi-Fang Ping, Xiao-Hong Yao, Chu-Hong Zhu, Hai-Tao Guo, Le-Yong Tan, Zhi-Yong Liang, Xiu-Wu Bian, Shu-Yang Zhang |
| 122 |
[GO] |
2022―Mai―27 |
Broadly recognized, cross-reactive SARS-CoV-2 CD4 T cell epitopes are highly conserved across human coronaviruses and presented by common HLA alleles |
Aniuska Becerra-Artiles, J. Mauricio Calvo-Calle, Mary Dawn Co, Padma P. Nanaware, John Cruz, Grant C. Weaver, Liying Lu, Catherine Forconi, Robert W. Finberg, Ann M. Moormann, Lawrence J. Stern |
| 123 |
[GO] |
2022―Mai―26 |
Parsing the role of NSP1 in SARS-CoV-2 infection |
Tal Fisher, Avi Gluck, Krishna Narayanan, Makoto Kuroda, Aharon Nachshon, Jason, C. Hsu, Peter J. Halfmann, Yfat Yahalom-Ronen, Hadas Tamir, Yaara Finkel, Michal Schwartz, Shay Weiss, Chien-Te K. Tseng, Tomer Israely, Nir Paran, Yoshihiro Kawaoka, Shinji Makino, Noam Stern-Ginossar |
| 124 |
[GO] |
2022―Mai―25 |
BARICITINIB ATTENUATES THE PROINFLAMMATORY PHASE OF COVID-19 DRIVEN BY LUNG-INFILTRATING MONOCYTES |
Brian Dobosh, Keivan Zandi, Diego Moncada Giraldo, Shu Ling Goh, Kathryn Musall, Milagros Aldeco, Julia LeCher, Vincent D. Giacalone, Junkai Yang, Devon Eddins, Manoj Bhasin, Eliver Ghosn, Vikas Sukhatme, Raymond F. Schinazi, Rabindra Tirouvanziam |
| 125 |
[GO] |
2022―Mai―25 |
Single cell RNA sequencing reveals immunological rewiring at the maternal-fetal interface following asymptomatic/mild SARS-CoV-2 infection |
Suhas Sureshchandra, Michael Z. Zulu, Brianna M. Doratt, Allen Jankeel, Delia Tifrea, Robert Edwards, Monica Rincon, Nicole E. Marshall, Ilhem Messaoudi |
| 126 |
[GO] |
2022―Mai―20 |
Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529 |
Qian Wang, Saumya Anang, Sho Iketani, Yicheng Guo, Lihong Liu, Phinikoula S. Katsamba, Lawrence Shapiro, David D. Ho, Joseph G. Sodroski |
| 127 |
[GO] |
2022―Mai―16 |
IgG targeting distinct seasonal coronavirus OC43-conserved SARS-CoV-2 spike subdomains correlate with differential COVID-19 disease outcomes |
Jose L. Garrido, Matías A. Medina, Felipe Bravo, Sarah McGee, Francisco Fuentes-Villalobos, Mario Calvo, Yazmin Pinos, James W. Bowman, Christopher D. Bahl, Maria Ines Barria, Rebecca A. Brachman, Raymond A. Alvarez |
| 128 |
[GO] |
2022―Mai―16 |
Ultrapotent and Broad Neutralization of SARS-CoV-2 Variants by Modular, Tetravalent, Bi-paratopic Antibodies |
Shane Miersch, Nitin Sharma, Reza Saberianfar, Chao Chen, Francesca Caccuri, Alberto Zani, Arnaldo Caruso, James Brett Case, Michael S. Diamond, Gaya K. Amarasinghe, Giuseppe Novelli, Sachdev S. Sidhu |
| 129 |
[GO] |
2022―Mai―08 |
Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron |
Siling Wang, Hui Sun, Yali Zhang, Lunzhi Yuan, Yizhen Wang, Tianying Zhang, Shaojuan Wang, Jinlei Zhang, Hai Yu, Hualong Xiong, Zimin Tang, Liqin Liu, Yang Huang, Xiuting Chen, Tingting Li, Dong Ying, Chang Liu, Zihao Chen, Quan Yuan, Jun Zhang, Tong Cheng, Shaowei Li, Yi Guan, Qingbing Zheng, Zizheng Zheng, Ningshao Xia |
| 130 |
[GO] |
2022―Mai―08 |
Longitudinal analyses reveal distinct immune response landscapes in lung and intestinal tissues from SARS-CoV-2-infected rhesus macaques |
Huiwen Zheng, Yanli Chen, Jing Li, Heng Li, Xin Zhao, Jiali Li, Fengmei Yang, Yanyan Li, Changkun Liu, Li Qin, Yuanyuan Zuo, Qian Zhang, Zhanlong He, Haijing Shi, Qihan Li, Longding Liu |
| 131 |
[GO] |
2022―Apr―29 |
Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant |
Yang Liu, Jianying Liu, Bryan A. Johnson, Hongjie Xia, Zhiqiang Ku, Craig Schindewolf, Steven G. Widen, Zhiqiang An, Scott C. Weaver, Vineet D. Menachery, Xuping Xie, Pei-Yong Shi |
| 132 |
[GO] |
2022―Apr―26 |
Characterization and functional interrogation of the SARS-CoV-2 RNA interactome |
Athéna Labeau, Luc Fery-Simonian, Alain Lefevre-Utile, Marie Pourcelot, Lucie Bonnet-Madin, Vassili Soumelis, Vincent Lotteau, Pierre-Olivier Vidalain, Ali Amara, Laurent Meertens |
| 133 |
[GO] |
2022―Apr―25 |
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants |
Kathryn Westendorf, Stefanie Žentelis, Lingshu Wang, Denisa Foster, Peter Vaillancourt, Matthew Wiggin, Erica Lovett, Robin van der Lee, Jörg Hendle, Anna Pustilnik, J. Michael Sauder, Lucas Kraft, Yuri Hwang, Robert W. Siegel, Jinbiao Chen, Beverly A. Heinz, Richard E. Higgs, Nicole L. Kallewaard, Kevin Jepson, Rodrigo Goya, Maia A. Smith, David W. Collins, Davide Pellacani, Ping Xiang, Valentine de Puyraimond, Marketa Ricicova, Lindsay Devorkin, Caitlin Pritchard, Aoise O’Neill, Kush Dalal, Pankaj Panwar, Harveer Dhupar, Fabian A. Garces, Courtney A. Cohen, John M. Dye, Kathleen E. Huie, Catherine V. Badger, Darwyn Kobasa, Jonathan Audet, Joshua J. Freitas, Saleema Hassanali, Ina Hughes, Luis Munoz, Holly C. Palma, Bharathi Ramamurthy, Robert W. Cross, Thomas W. Geisbert, Vineet Menacherry, Kumari Lokugamage, Viktoriya Borisevich, Iliana Lanz, Lisa Anderson, Payal Sipahimalani, Kizzmekia S. Corbett, Eun Sung Yang, Yi Zhang, Wei Shi, Tongqing Zhou, Misook Choe, John Misasi, Peter D. Kwong, Nancy J. Sullivan, Barney S. Graham, Tara L. Fernandez, Carl L. Hansen, Ester Falconer, John R. Mascola, Bryan E. Jones, Bryan C. Barnhart |
| 134 |
[GO] |
2022―Apr―21 |
Nasally-delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron |
Zhenlu Chong, Courtney E. Karl, Peter J. Halfmann, Yoshihiro Kawaoka, Emma S. Winkler, Shamus P. Keeler, Michael J. Holtzman, Jinsheng Yu, Michael S. Diamond |
| 135 |
[GO] |
2022―Apr―19 |
Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry |
Enya Qing, Pengfei Li, Laura Cooper, Sebastian Schulz, Hans-Martin Jäck, Lijun Rong, Stanley Perlman, Tom Gallagher |
| 136 |
[GO] |
2022―Apr―15 |
SARS-CoV-2 variants C.1.2 and B.1.621 (Mu) partially evade neutralization by antibodies elicited upon infection or vaccination |
Prerna Arora, Amy Kempf, Inga Nehlmeier, Luise Graichen, Martin S. Winkler, Martin Lier, Sebastian Schulz, Hans-Martin Jäck, Anne Cossmann, Metodi V. Stankov, Georg M.N. Behrens, Stefan Pöhlmann, Markus Hoffmann |
| 137 |
[GO] |
2022―Apr―15 |
ChAdOx1 nCoV-19 (AZD1222) vaccine elicits monoclonal antibodies with potent cross-neutralizing activity against SARS-CoV-2 viral variants |
Jeffrey Seow, Carl Graham, Sadie R. Hallett, Thomas Lechmere, Thomas J.A. Maguire, Isabella Huettner, Daniel Cox, Hataf Khan, Suzanne Pickering, Rebekah Roberts, Anele Waters, Christopher C. Ward, Christine Mant, Michael J. Pitcher, Jo Spencer, Julie Fox, Michael H. Malim, Katie J. Doores |
| 138 |
[GO] |
2022―Apr―11 |
Structural and functional impact by SARS-CoV-2 Omicron spike mutations |
Jun Zhang, Yongfei Cai, Christy L. Lavine, Hanqin Peng, Haisun Zhu, Krishna Anand, Pei Tong, Avneesh Gautam, Megan L. Mayer, Sophia Rits-Volloch, Shaowei Wang, Piotr Sliz, Duane R. Wesemann, Wei Yang, Michael S. Seaman, Jianming Lu, Tianshu Xiao, Bing Chen |
| 139 |
[GO] |
2022―Apr―09 |
Dynamic Ca2+ sensitivity stimulates the evolved SARS-CoV-2 spike strain-mediated membrane fusion for enhanced entry |
Puspangana Singh, Shreya Mukherji, Swarnendu Basak, Markus Hoffmann, Dibyendu Kumar Das |
| 140 |
[GO] |
2022―Apr―04 |
Humanized mice reveal a macrophage-enriched gene signature defining human lung tissue protection during SARS-CoV-2 infection |
Devin J. Kenney, Aoife K. O’Connell, Jacquelyn Turcinovic, Paige Montanaro, Ryan M. Hekman, Tomokazu Tamura, Andrew R. Berneshawi, Thomas R. Cafiero, Salam Al Abdullatif, Benjamin Blum, Stanley I. Goldstein, Brigitte L. Heller, Hans P. Gertje, Esther Bullitt, Alexander J. Trachtenberg, Elizabeth Chavez, Evans Tuekam Nono, Catherine Morrison, Anna E. Tseng, Amira Sheikh, Susanna Kurnick, Kyle Grosz, Markus Bosmann, Maria Ericsson, Bertrand R. Huber, Mohsan Saeed, Alejandro B. Balazs, Kevin P. Francis, Alexander Klose, Neal Paragas, Joshua D. Campbell, John H. Connor, Andrew Emili, Nicholas A. Crossland, Alexander Ploss, Florian Douam |
| 141 |
[GO] |
2022―Mrz―25 |
mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron |
Hye Kyung Lee, Ludwig Knabl, Juan I. Moliva, Ludwig Knabl, Anne P. Werner, Seyhan Boyoglu-Barnum, Sebastian Kapferer, Birgit Pateter, Mary Walter, Nancy J. Sullivan, Priscilla A. Furth, Lothar Hennighausen |
| 142 |
[GO] |
2022―Mrz―07 |
Cross-species tropism and antigenic landscapes of circulating SARS-CoV-2 variants |
Yali Zhang, Min Wei, Yangtao Wu, Juan Wang, Yuting Hong, Yang Huang, Lunzhi Yuan, Jian Ma, Kai Wang, Shaojuan Wang, Yang Shi, Zikang Wang, Huilin Guo, Jin Xiao, Chuanlai Yang, Jianghui Ye, Jijing Chen, Yuxi Liu, Baorong Fu, Miaolin Lan, Peixuan Gong, Zehong Huang, Yingying Su, Yixin Chen, Tianying Zhang, Jun Zhang, Huachen Zhu, Hai Yu, Quan Yuan, Tong Cheng, Yi Guan, Ningshao Xia |
| 143 |
[GO] |
2022―Mrz―07 |
Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting |
Blake M. Hauser, Maya Sangesland, Kerri J. St. Denis, Evan C. Lam, James Brett Case, Ian W. Windsor, Jared Feldman, Timothy M. Caradonna, Ty Kannegieter, Michael S. Diamond, Alejandro B. Balazs, Daniel Lingwood, Aaron G. Schmidt |
| 144 |
[GO] |
2022―Feb―22 |
SARS-CoV-2 reinfection prevents acute respiratory disease in Syrian hamsters but not replication in the upper respiratory tract |
Frederick Hansen, Kimberly Meade-White, Chad Clancy, Rebecca Rosenke, Atsushi Okumura, David W. Hawman, Friederike Feldmann, Benjamin Kaza, Michael A. Jarvis, Kyle Rosenke, Heinz Feldmann |
| 145 |
[GO] |
2022―Feb―21 |
Limited Extent and Consequences of Pancreatic SARS-CoV-2 Infection |
Verena van der Heide, Sonia Jangra, Phillip Cohen, Raveen Rathnasinghe, Sadaf Aslam, Teresa Aydillo, Daniel Geanon, Diana Handler, Geoffrey Kelley, Brian Lee, Adeeb Rahman, Travis Dawson, Jingjing Qi, Darwin D’Souza, Seunghee Kim-Schulze, Julia K. Panzer, Alejandro Caicedo, Irina Kusmartseva, Amanda L. Posgai, Mark A. Atkinson, Randy A. Albrecht, Adolfo García-Sastre, Brad R. Rosenberg, Michael Schotsaert, Dirk Homann |
| 146 |
[GO] |
2022―Feb―21 |
SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells |
Quirin Hammer, Josefine Dunst, Wanda Christ, Francesca Picarazzi, Mareike Wendorff, Pouria Momayyezi, Oisín Huhn, Herman K. Netskar, Kimia T. Maleki, Marina García, Takuya Sekine, Ebba Sohlberg, Valerio Azzimato, Myriam Aouadi, Frauke Degenhardt, Andre Franke, Francesco Spallotta, Mattia Mori, Jakob Michaëlsson, Niklas K. Björkström, Timo Rückert, Chiara Romagnani, Amir Horowitz, Jonas Klingström, Hans-Gustaf Ljunggren, Karl-Johan Malmberg |
| 147 |
[GO] |
2022―Feb―21 |
BCG vaccination provides protection against IAV but not SARS-CoV-2 |
Eva Kaufmann, Nargis Khan, Kim A. Tran, Antigona Ulndreaj, Erwan Pernet, Ghislaine Fontes, Andréanne Lupien, Patrice Desmeules, Fiona McIntosh, Amina Abow, Simone J.C.F.M. Moorlag, Priya Debisarun, Karen Mossman, Arinjay Banerjee, Danielle Karo-Atar, Mina Sadeghi, Samira Mubareka, Donald C. Vinh, Irah L. King, Clinton S. Robbins, Marcel A. Behr, Mihai G. Netea, Philippe Joubert, Maziar Divangahi |
| 148 |
[GO] |
2022―Feb―08 |
SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-weeks interval between doses |
Debashree Chatterjee, Alexandra Tauzin, Lorie Marchitto, Shang Yu Gong, Marianne Boutin, Catherine Bourassa, Guillaume Beaudoin-Bussières, Yuxia Bo, Shilei Ding, Annemarie Laumaea, Dani Vézina, Josée Perreault, Laurie Gokool, Chantal Morrisseau, Pascale Arlotto, Éric Fournier, Aurélie Guilbault, Benjamin Delisle, Inès Levade, Guillaume Goyette, Gabrielle Gendron-Lepage, Halima Medjahed, Gaston De Serres, Cécile Tremblay, Valérie Martel-Laferrière, Daniel E. Kaufmann, Renée Bazin, Jérémie Prévost, Sandrine Moreira, Jonathan Richard, Marceline Côté, Andrés Finzi |
| 149 |
[GO] |
2022―Feb―07 |
Cryo-EM structure of the SARS-CoV-2 omicron spike |
Gabriele Cerutti, Yicheng Guo, Lihong Liu, Liyuan Liu, Zhening Zhang, Yang Luo, Yiming Huang, Harris H. Wang, David D. Ho, Zizhang Sheng, Lawrence Shapiro |
| 150 |
[GO] |
2022―Feb―01 |
Follicular T Cells Optimize the Germinal Center Response to SARS-CoV-2 Protein Vaccination in Mice |
Cecilia B. Cavazzoni, Benjamin L. Hanson, Manuel A. Podestà, Elsa D. Bechu, Rachel L. Clement, Hengcheng Zhang, Joe Daccache, Tamara Reyes-Robles, Erik C. Hett, Kalpit A. Vora, Olugbeminiyi O. Fadeyi, Rob C. Oslund, Daria J. Hazuda, Peter T. Sage |
| 151 |
[GO] |
2022―Jan―31 |
Long-term, infection-acquired immunity against the SARS-CoV-2 Delta variant in a hamster model |
Peter J. Halfmann, Makoto Kuroda, Tammy Armbrust, Molly Accola, Riccardo Valdez, Theresa Kowalski-Dobson, William Rehrauer, Aubree Gordon, Yoshihiro Kawaoka |
| 152 |
[GO] |
2022―Jan―31 |
B cell receptor repertoire kinetics after SARS-CoV-2 infection and vaccination |
Prasanti Kotagiri, Federica Mescia, William M. Rae, Laura Bergamaschi, Zewen K. Tuong, Lorinda Turner, Kelvin Hunter, Pehuén P. Gerber, Myra Hosmillo, Christoph Hess, Menna R. Clatworthy, Ian G. Goodfellow, Nicholas J. Matheson, Eoin F. McKinney, Mark R. Wills, Ravindra K. Gupta, John R. Bradley, Rachael J.M. Bashford-Rogers, Paul A. Lyons, Kenneth G.C. Smith |
| 153 |
[GO] |
2022―Jan―28 |
SARS-CoV-2 variants of concern display enhanced intrinsic pathogenic properties and expanded organ tropism in mouse models |
Bettina Stolp, Marcel Stern, Ina Ambiel, Katharina Hofmann, Katharina Morath, Lara Gallucci, Mirko Cortese, Ralf Bartenschlager, Alessia Ruggieri, Frederik Graw, Martina Rudelius, Oliver Till Keppler, Oliver Till Fackler |
| 154 |
[GO] |
2022―Jan―25 |
A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection |
Guillaume Beaudoin-Bussières, Yaozong Chen, Irfan Ullah, Jérémie Prévost, William D. Tolbert, Kelly Symmes, Shilei Ding, Mehdi Benlarbi, Shang Yu Gong, Alexandra Tauzin, Romain Gasser, Debashree Chatterjee, Dani Vézina, Guillaume Goyette, Jonathan Richard, Fei Zhou, Leonidas Stamatatos, Andrew T. McGuire, Hughes Charest, Michel Roger, Edwin Pozharski, Priti Kumar, Walther Mothes, Pradeep D. Uchil, Marzena Pazgier, Andrés Finzi |
| 155 |
[GO] |
2022―Jan―20 |
SARS-CoV-2 mRNA Vaccine Induces Robust Specific and Cross-reactive IgG and Unequal Neutralizing Antibodies in Naïve and Previously Infected Recipients |
Tara M. Narowski, Kristin Raphel, Lily E. Adams, Jenny Huang, Nadja A. Vielot, Ramesh Jadi, Aravinda M. de Silva, Ralph S. Baric, John E. Lafleur, Lakshmanane Premkumar |
| 156 |
[GO] |
2022―Jan―20 |
Rapid Identification of Neutralizing Antibodies against SARS-CoV-2 Variants by mRNA Display |
Shiho Tanaka, C. Anders Olson, Christopher O. Barnes, Wendy Higashide, Marcos Gonzalez, Justin Taft, Ashley Richardson, Marta Martin-Fernandez, Dusan Bogunovic, Priyanthi N.P. Gnanapragasam, Pamela J. Bjorkman, Patricia Spilman, Kayvan Niazi, Shahrooz Rabizadeh, Patrick Soon-Shiong |
| 157 |
[GO] |
2022―Jan―19 |
Maintenance of broad neutralising antibodies and memory B cells 12 months post-infection is predicted by SARS-CoV-2 specific CD4+ T cell responses |
Harikrishnan Balachandran, Chansavath Phetsouphanh, David Agapiou, Anurag Adhikari, Chaturaka Rodrigo, Mohamed Hammoud, Lok Bahadur Shrestha, Elizabeth Keoshkerian, Money Gupta, Stuart Turville, Daniel Christ, Cecile King, Sarah C. Sasson, Adam Bartlett, Branka Grubor-Bauk, William Rawlinson, Anupriya Aggarwal, Alberto Ospina Stella, Vera Klemm, Michael M. Mina, Jeffrey J. Post, Bernard Hudson, Nicky Gilroy, Pam Konecny, Golo Ahlenstiel, Dominic E. Dwyer, Tania C. Sorrell, Anthony Kelleher, Nicodemus Tedla, Andrew R. Lloyd, Marianne Martinello, Rowena A. Bull |
| 158 |
[GO] |
2022―Jan―19 |
Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway. |
Jie Zhou, Thomas P. Peacock, Jonathan C. Brown, Daniel H. Goldhill, Ahmed M.E. Elrefaey, Rebekah Penrice-Randal, Vanessa M. Cowton, Giuditta De Lorenzo, Wilhelm Furnon, William T. Harvey, Ruthiran Kugathasan, Rebecca Frise, Laury Baillon, Ria Lassaunière, Nazia Thakur, Giulia Gallo, Hannah Goldswain, I’ah Donovan-Banfield, Xiaofeng Dong, Nadine P. Randle, Fiachra Sweeney, Martha C. Glynn, Jessica L. Quantrill, Paul F. McKay, Arvind H. Patel, Massimo Palmarini, Julian A. Hiscox, Dalan Bailey, Wendy S. Barclay |
| 159 |
[GO] |
2022―Jan―11 |
Nucleic acid delivery of immune-focused SARS-CoV-2 nanoparticles drive rapid and potent immunogenicity capable of single-dose protection |
Kylie M. Konrath, Kevin Liaw, Yuanhan Wu, Xizhou Zhu, Susanne N. Walker, Ziyang Xu, Katherine Schultheis, Neethu Chokkalingam, Himanshi Chawla, Jianqiu Du, Nicholas J. Tursi, Alan Moore, Jared Adolf-Bryfogle, Mansi Purwar, Emma L. Reuschel, Drew Frase, Matthew Sullivan, Benjamin Fry, Igor Maricic, Viviane M. Andrade, Christel Iffland, Max Crispin, Kate E. Broderick, Laurent M.P. F. Humeau, Ami Patel, Trevor R.F. Smith, Jesper Pallesen, David B. Weiner, Daniel W. Kulp |
| 160 |
[GO] |
2021―Dez―28 |
Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19 |
Xiaojie Bi, Wei Liu, Xuan Ding, Shuang Liang, Yufen Zheng, Xiaoli Zhu, Sheng Quan, Xiao Yi, Nan Xiang, Juping Du, Haiyan Lyu, Die Yu, Chao Zhang, Luang Xu, Weigang Ge, Xinke Zhan, Jiale He, Zi Xiong, Shun Zhang, Yanchang Li, Ping Xu, Guangjun Zhu, Donglian Wang, Hongguo Zhu, Shiyong Chen, Jun Li, Haihong Zhao, Yi Zhu, Huafen Liu, Jiaqin Xu, Bo Shen, Tiannan Guo |
| 161 |
[GO] |
2021―Dez―23 |
A Bivalent Nanoparticle Vaccine Exhibits Potent Cross-protection against the Variants of SARS-CoV-2 |
Yaochang Yuan, Xiantao Zhang, Ran Chen, Yuzhuang Li, Bolin Wu, Rong Li, Fan Zou, Xiancai Ma, Xuemei Wang, Qier Chen, Jieyi Deng, Yongli Zhang, Tao Chen, Yingtong Lin, Shumei Yan, Xu Zhang, Congrong Li, Xiuqing Bu, Yi Peng, Changwen Ke, Kai Deng, Ting Pan, Xin He, Yiwen Zhang, Hui Zhang |
| 162 |
[GO] |
2021―Dez―22 |
SARS-CoV-2 reactive and neutralizing antibodies discovered by single cell sequencing of plasma cells and mammalian display |
Roy A. Ehling, Cédric R. Weber, Derek M. Mason, Simon Friedensohn, Bastian Wagner, Florian Bieberich, Edo Kapetanovic, Rodrigo Vazquez-Lombardi, Raphaël B. Di Roberto, Kai-Lin Hong, Camille Wagner, Michele Pataia, Max Overath, Daniel J. Sheward, Ben Murrell, Alexander Yermanos, Andreas P. Cuny, Miodrag Savic, Fabian Rudolf, Sai T. Reddy |
| 163 |
[GO] |
2021―Dez―21 |
Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naïve and subjects recovered from COVID-19 |
Roberto Lozano-Rodríguez, Jaime Valentín-Quiroga, José Avendaño-Ortiz, Alejandro Martín-Quirós, Alejandro Pascual-Iglesias, Verónica Terrón, Karla Montalbán-Hernández, José Carlos Casalvilla-Dueñas, Marta Bergón-Gutiérrez, José Alcamí, Javier Garcia-Pérez, Almudena Cascajero, Miguel Ángel García-Garrido, Álvaro del Balzo-Castillo, María Peinado, Laura Gómez, Irene Llorente-Fernández, Gema Martín-Miguel, Carmen Herrero-Benito, José Miguel Benito, Norma Rallón, Carmen Vela-Olmo, Lissette López-Morejón, Carolina Cubillos-Zapata, Luis A. Aguirre, Carlos del Fresno, Eduardo López-Collazo |
| 164 |
[GO] |
2021―Dez―21 |
High Titer Neutralization of Mu and C.1.2 SARS-CoV-2 Variants by Vaccine-elicited Antibodies of Previously Infected Individuals |
Takuya Tada, Hao Zhou, Belinda M. Dcosta, Marie I. Samanovic, Amber Cornelius, Ramin S. Herati, Mark J. Mulligan, Nathaniel R. Landau |
| 165 |
[GO] |
2021―Dez―21 |
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies |
Claudia A. Jette, Alexander A. Cohen, Priyanthi N.P. Gnanapragasam, Frauke Muecksch, Yu E. Lee, Kathryn E. Huey-Tubman, Fabian Schmidt, Theodora Hatziioannou, Paul D. Bieniasz, Michel C. Nussenzweig, Anthony P. West, Jennifer R. Keeffe, Pamela J. Bjorkman, Christopher O. Barnes |
| 166 |
[GO] |
2021―Dez―18 |
The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance |
Izumi Kimura, Yusuke Kosugi, Jiaqi Wu, Jiri Zahradnik, Daichi Yamasoba, Erika P. Butlertanaka, Yuri L. Tanaka, Keiya Uriu, Yafei Liu, Nanami Morizako, Kotaro Shirakawa, Yasuhiro Kazuma, Ryosuke Nomura, Yoshihito Horisawa, Kenzo Tokunaga, Takamasa Ueno, Akifumi Takaori-Kondo, Gideon Schreiber, Hisashi Arase, Chihiro Motozono, Akatsuki Saito, So Nakagawa, Kei Sato |
| 167 |
[GO] |
2021―Dez―17 |
Recruitment of highly cytotoxic CD8+ T cell receptors in mild SARS-CoV-2 infection |
Karolin I. Wagner, Laura M. Mateyka, Sebastian Jarosch, Vincent Grass, Simone Weber, Kilian Schober, Monika Hammel, Teresa Burrell, Behnam Kalali, Holger Poppert, Henriette Beyer, Sophia Schambeck, Stefan Holdenrieder, Andrea Strötges-Achatz, Verena Haselmann, Michael Neumaier, Johanna Erber, Alina Priller, Sarah Yazici, Hedwig Roggendorf, Marcus Odendahl, Torsten Tonn, Andrea Dick, Klaus Witter, Hrvoje Mijočević, Ulrike Protzer, Percy A. Knolle, Andreas Pichlmair, Claudia S. Crowell, Markus Gerhard, Elvira D’Ippolito, Dirk H. Busch |
| 168 |
[GO] |
2021―Dez―16 |
Two-step fitness selection for intra-host variations in SARS-CoV-2 |
Jiarui Li, Pengcheng Du, Lijiang Yang, Ju Zhang, Chuan Song, Danying Chen, Yangzi Song, Nan Ding, Mingxi Hua, Kai Han, Rui Song, Wen Xie, Zhihai Chen, Xianbo Wang, Jingyuan Liu, Yanli Xu, Guiju Gao, Qi Wang, Lin Pu, Lin Di, Jie Li, Jinglin Yue, Junyan Han, Xuesen Zhao, Yonghong Yan, Fengting Yu, Angela R. Wu, Fujie Zhang, Yi Qin Gao, Yanyi Huang, Jianbin Wang, Hui Zeng, Chen Chen |
| 169 |
[GO] |
2021―Dez―15 |
Structural Basis and Mode of Action for Two Broadly Neutralizing Antibodies Against SARS-CoV-2 Emerging Variants of Concern |
Wenwei Li, Yaozong Chen, Jérémie Prévost, Irfan Ullah, Maolin Lu, Shang Yu Gong, Alexandra Tauzin, Romain Gasser, Dani Vézina, Sai Priya Anand, Guillaume Goyette, Debashree Chaterjee, Shilei Ding, William D. Tolbert, Michael W. Grunst, Yuxia Bo, Shijian Zhang, Jonathan Richard, Fei Zhou, Rick K. Huang, Lothar Esser, Allison Zeher, Marceline Côté, Priti Kumar, Joseph Sodroski, Di Xia, Pradeep D. Uchil, Marzena Pazgier, Andrés Finzi, Walther Mothes |
| 170 |
[GO] |
2021―Dez―10 |
HLA-A∗02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronaviruses |
Pavlo A. Nesterenko, Jami McLaughlin, Brandon L. Tsai, Giselle Burton Sojo, Donghui Cheng, Daniel Zhao, Zhiyuan Mao, Nathanael J. Bangayan, Matthew B. Obusan, Yapeng Su, Rachel H. Ng, William Chour, Jingyi Xie, Yan-Ruide Li, Derek Lee, Miyako Noguchi, Camille Carmona, John W. Phillips, Jocelyn T. Kim, Lili Yang, James R. Heath, Paul C. Boutros, Owen N. Witte |
| 171 |
[GO] |
2021―Dez―08 |
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity |
M. Gordon Joyce, Wei-Hung Chen, Rajeshwer S. Sankhala, Agnes Hajduczki, Paul V. Thomas, Misook Choe, Elizabeth Martinez, William Chang, Caroline E. Peterson, Elaine B. Morrison, Clayton Smith, Rita E. Chen, Aslaa Ahmed, Lindsay Wieczorek, Alexander Anderson, James Brett Case, Yifan Li, Therese Oertel, Lorean Rosado, Akshaya Ganesh, Connor Whalen, Joshua M. Carmen, Letzibeth Mendez-Rivera, Christopher Karch, Neelakshi Gohain, Zuzana Villar, David McCurdy, Zoltan Beck, Jiae Kim, Shikha Shrivastava, Ousman Jobe, Vincent Dussupt, Sebastian Molnar, Ursula Tran, Chandrika B. Kannadka, Sandrine Soman, Caitlin Kuklis, Michelle Zemil, Htet Khanh, Weimin Wu, Matthew A. Cole, Debra K. Duso, Larry W. Kummer, Tricia J. Lang, Shania E. Muncil, Jeffrey R. Currier, Shelly J. Krebs, Victoria R. Polonis, Saravanan Rajan, Patrick M. McTamney, Mark T. Esser, William W. Reiley, Morgane Rolland, Natalia de Val, Michael S. Diamond, Gregory D. Gromowski, Gary R. Matyas, Mangala Rao, Nelson L. Michael, Kayvon Modjarrad |
| 172 |
[GO] |
2021―Dez―07 |
Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses |
Paul R. Wratil, Niklas A. Schmacke, Burak Karakoc, Alex Dulovic, Daniel Junker, Matthias Becker, Ulrich Rothbauer, Andreas Osterman, Patricia M. Spaeth, Adrian Ruhle, Madeleine Gapp, Stephanie Schneider, Maximilian Muenchhoff, Johannes C. Hellmuth, Clemens Scherer, Julia Mayerle, Martin Reincke, Juergen Behr, Stefan Kääb, Bernhard Zwissler, Michael von Bergwelt-Baildon, Josef Eberle, Lars Kaderali, Nicole Schneiderhan-Marra, Veit Hornung, Oliver T. Keppler |
| 173 |
[GO] |
2021―Dez―04 |
Structural Analysis of Receptor Binding Domain Mutations in SARS-CoV-2 Variants of Concern that Modulate ACE2 and Antibody Binding |
Dhiraj Mannar, James W. Saville, Xing Zhu, Shanti S. Srivastava, Alison M. Berezuk, Steven Zhou, Katharine S. Tuttle, Andrew Kim, Wei Li, Dimiter S. Dimitrov, Sriram Subramaniam |
| 174 |
[GO] |
2021―Dez―03 |
IFP35 as a promising biomarker and therapeutic target for the syndromes induced by SARS-CoV-2 or influenza virus |
Yang Yu, Na Xu, Qi Cheng, Fei Deng, Meiqin Liu, Airu Zhu, Yuan-Qin Min, Dan Zhu, Wenbo Huang, Xu Feng, Xizhong Jing, Ying Chen, Daoyuan Yue, Yawei Fan, Chang Shu, Qing Guan, Zifeng Yang, Jincun Zhao, Wenjun Song, Deyin Guo, Huanliang Liu, Jindong Zhao, Ping Lan, Zhengli Shi, Yingfang Liu, Xiaoping Chen, Huanhuan Liang |
| 175 |
[GO] |
2021―Nov―24 |
Anti-SARS-CoV-2 antibodies elicited by COVID-19mRNA vaccine exhibit a unique glycosylation pattern |
Inbal Farkash, Tali Feferman, Noy Cohen-Saban, Yahel Avraham, David Morgenstern, Grace Mayuni, Natasha Barth, Yaniv Lustig, Liron Miller, Dror S. Shouval, Asaf Biber, Ilya Kirgner, Yishai Levin, Rony Dahan |
| 176 |
[GO] |
2021―Nov―24 |
Two-adjuvant multiantigen candidate vaccine induces superior protective immune responses against SARS-CoV-2 challenge |
Wenwen Jiang, Li Shi, Lukui Cai, Xiaoyu Wang, Jingyan Li, Heng Li, Jiangli Liang, Qin Gu, Guang Ji, Jing Li, Longding Liu, Mingbo Sun |
| 177 |
[GO] |
2021―Nov―10 |
Contribution of autophagy machinery factors to HCV and SARS-CoV-2 replication organelle formation |
Woan-Ing Twu, Ji-Young Lee, Heeyoung Kim, Vibhu Prasad, Berati Cerikan, Uta Haselmann, Keisuke Tabata, Ralf Bartenschlager |
| 178 |
[GO] |
2021―Nov―03 |
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a wide variety of tissues |
Matteo D’Antonio, Jennifer P. Nguyen, Timothy D. Arthur, Hiroko Matsui, Agnieszka D’Antonio-Chronowska, Kelly A. Frazer |
| 179 |
[GO] |
2021―Okt―22 |
Selective functional antibody transfer into the breastmilk after SARS-CoV-2 infection |
Krista M. Pullen, Caroline Atyeo, Ai-Ris Y. Collier, Kathryn J. Gray, Mandy B. Belfort, Douglas A. Lauffenburger, Andrea G. Edlow, Galit Alter |
| 180 |
[GO] |
2021―Okt―22 |
Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome |
Weifan Xu, Gaofeng Pei, Hongrui Liu, Xiaohui Ju, Jing Wang, Qiang Ding, Pilong Li |
| 181 |
[GO] |
2021―Okt―20 |
Monoclonal antibodies protect aged rhesus macaques from SARS-CoV-2-induced immune activation and neuroinflammation |
Anil Verma, Chase E. Hawes, Yashavanth Shaan Lakshmanappa, Jamin W. Roh, Brian A. Schmidt, Joseph Dutra, William Louie, Hongwei Liu, Zhong-Min Ma, Jennifer K. Watanabe, Jodie L. Usachenko, Ramya Immareddy, Rebecca L. Sammak, Rachel Pollard, J. Rachel Reader, Katherine J. Olstad, Lark L. Coffey, Pamela A. Kozlowski, Dennis J. Hartigan-O’Connor, Michel Nussenzweig, Koen K.A. Van Rompay, John H. Morrison, Smita S. Iyer |
| 182 |
[GO] |
2021―Okt―19 |
Stabilized Coronavirus Spike Stem Elicits a Broadly Protective Antibody |
Ching-Lin Hsieh, Anne P. Werner, Sarah R. Leist, Laura J. Stevens, Ester Falconer, Jory A. Goldsmith, Chia-Wei Chou, Olubukola M. Abiona, Ande West, Kathryn Westendorf, Krithika Muthuraman, Ethan J. Fritch, Kenneth H. Dinnon, Alexandra Schäfer, Mark R. Denison, James D. Chappell, Ralph S. Baric, Barney S. Graham, Kizzmekia S. Corbett, Jason S. McLellan |
| 183 |
[GO] |
2021―Okt―19 |
Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain |
Gabriele Cerutti, Yicheng Guo, Pengfei Wang, Manoj S. Nair, Maple Wang, Yaoxing Huang, Jian Yu, Lihong Liu, Phinikoula S. Katsamba, Fabiana Bahna, Eswar R. Reddem, Peter D. Kwong, David D. Ho, Zizhang Sheng, Lawrence Shapiro |
| 184 |
[GO] |
2021―Okt―16 |
An Airway Organoid-Based Screen Identifies a Role for the HIF1α-Glycolysis Axis in SARS-CoV-2 Infection |
Xiaohua Duan, Xuming Tang, Manoj S. Nair, Tuo Zhang, Yunping Qiu, Wei Zhang, Pengfei Wang, Yaoxing Huang, Jenny Xiang, Hui Wang, Robert E. Schwartz, David D. Ho, Todd Evans, Shuibing Chen |
| 185 |
[GO] |
2021―Okt―12 |
Mechanistic Insights into COVID-19 by Global Analysis of the SARS-CoV-2 3CLpro Substrate Degradome |
Isabel Pablos, Yoan Machado, Hugo C. Ramos de Jesus, Yasir Mohamud, Reinhild Kappelhoff, Cecilia Lindskog, Marli Vlok, Peter A. Bell, Georgina S. Butler, Peter M. Grin, Quynh T. Cao, Jenny P. Nguyen, Nestor Solis, Srinivas Abbina, Wioletta Rut, John C. Vederas, Laszlo Szekely, Attila Szakos, Marcin Drag, Jayachandran N. Kizhakkedathu, Karen Mossman, Jeremy A. Hirota, Eric Jan, Honglin Luo, Arinjay Banerjee, Christopher M. Overall |
| 186 |
[GO] |
2021―Okt―09 |
Structural mechanism of SARS-CoV-2 neutralization by two murine antibodies targeting the RBD |
John M. Errico, Haiyan Zhao, Rita E. Chen, Zhuoming Liu, James Brett Case, Meisheng Ma, Aaron J. Schmitz, Michael J. Rau, James A.J. Fitzpatrick, Pei-Yong Shi, Michael S. Diamond, Sean P.J. Whelan, Ali H. Ellebedy, Daved H. Fremont |
| 187 |
[GO] |
2021―Okt―09 |
Remdesivir overcomes the S861 roadblock in SARS-CoV-2 polymerase elongation complex |
Jiqin Wu, Haofeng Wang, Qiaojie Liu, Rui Li, Yan Gao, Xiang Fang, Yao Zhong, Meihua Wang, Quan Wang, Zihe Rao, Peng Gong |
| 188 |
[GO] |
2021―Okt―08 |
A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration |
Xilin Wu, Lin Cheng, Ming Fu, Bilian Huang, Linjing Zhu, Shijie Xu, Haixia Shi, Doudou Zhang, Huanyun Yuan, Waqas Nawaz, Ping Yang, Qinxue Hu, Yalan Liu, Zhiwei Wu |
| 189 |
[GO] |
2021―Okt―06 |
In vivo characterization of emerging SARS-CoV-2 variant infectivity and human antibody escape potential |
Brandon Lam, Yu Jui Kung, John Lin, Ssu-Hsueh Tseng, Ya Chea Tsai, Liangmei He, Gianni Castiglione, Emily Egbert, Elia J. Duh, Evan M. Bloch, Aaron A.R. Tobian, Aaron M. Milstone, Richard B.S. Roden, T.C. Wu, Chien-Fu Hung |
| 190 |
[GO] |
2021―Sep―30 |
Role of miR-2392 in Driving SARS-CoV-2 Infection |
J. Tyson McDonald, Francisco Javier Enguita, Deanne Taylor, Robert J. Griffin, Waldemar Priebe, Mark R. Emmett, Mohammad M. Sajadi, Anthony D. Harris, Jean Clement, Joseph M. Dybas, Nukhet Aykin-Burns, Joseph W. Guarnieri, Larry N. Singh, Peter Grabham, Stephen B. Baylin, Aliza Yousey, Andrea N. Pearson, Peter M. Corry, Amanda Saravia-Butler, Thomas R. Aunins, Sadhana Sharma, Prashant Nagpal, Cem Meydan, Jonathan Foox, Christopher Mozsary, Bianca Cerqueira, Viktorija Zaksas, Urminder Singh, Eve Syrkin Wurtele, Sylvain V. Costes, Gustavo Gastão Davanzo, Diego Galeano, Alberto Paccanaro, Suzanne L. Meinig, Robert S. Hagan, Natalie M. Bowman, Matthew C. Wolfgang, Selin Altinok, Nicolae Sapoval, Todd J. Treangen, Pedro M. Moraes-Vieira, Charles Vanderburg, Douglas C. Wallace, Jonathan Schisler, Christopher E. Mason, Anushree Chatterjee, Robert Meller, Afshin Beheshti |
| 191 |
[GO] |
2021―Sep―30 |
The N-terminal domain of SARS-CoV-2 nsp1 plays key roles in suppression of cellular gene expression and preservation of viral gene expression |
Aaron S. Mendez, Michael Ly, Angélica M. González-Sánchez, Ella Hartenian, Nicholas T. Ingolia, Jamie H. Cate, Britt A. Glaunsinger |
| 192 |
[GO] |
2021―Sep―28 |
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses |
Bailey B. Banach, Gabriele Cerutti, Ahmed S. Fahad, Chen-Hsiang Shen, Matheus Oliveira De Souza, Phinikoula S. Katsamba, Yaroslav Tsybovsky, Pengfei Wang, Manoj S. Nair, Yaoxing Huang, Irene M. Francino-Urdániz, Paul J. Steiner, Matías Gutiérrez-González, Lihong Liu, Sheila N. López Acevedo, Alexandra F. Nazzari, Jacy R. Wolfe, Yang Luo, Adam S. Olia, I-Ting Teng, Jian Yu, Tongqing Zhou, Eswar R. Reddem, Jude Bimela, Xiaoli Pan, Bharat Madan, Amy D. Laflin, Rajani Nimrania, Kwok-Yung Yuen, Timothy A. Whitehead, David D. Ho, Peter D. Kwong, Lawrence Shapiro, Brandon J. DeKosky |
| 193 |
[GO] |
2021―Sep―27 |
High affinity memory B cells induced by SARS-CoV-2 infection produce more plasmablasts and atypical memory B cells than those primed by mRNA vaccines |
Kathryn A. Pape, Thamotharampillai Dileepan, Amanda J. Kabage, Daria Kozysa, Rodolfo Batres, Clayton Evert, Michael Matson, Sharon Lopez, Peter D. Krueger, Carolyn Graiziger, Byron P. Vaughn, Eugenia Shmidt, Joshua Rhein, Timothy W. Schacker, Alexander Khoruts, Marc K. Jenkins |
| 194 |
[GO] |
2021―Sep―27 |
Landscape of human antibody recognition of the SARS-CoV-2 Receptor Binding Domain |
Adam K. Wheatley, Phillip Pymm, Robyn Esterbauer, Melanie H. Dietrich, Wen Shi Lee, Damien Drew, Hannah G. Kelly, Li-Jin Chan, Francesca L. Mordant, Katrina A. Black, Amy Adair, Hyon-Xhi Tan, Jennifer A. Juno, Kathleen M. Wragg, Thakshila Amarasena, Ester Lopez, Kevin J. Selva, Ebene R. Haycroft, James P. Cooney, Hariprasad Venugopal, Li Lynn Tan, Matthew T. O’ Neill, Cody C. Allison, Deborah Cromer, Miles P. Davenport, Richard A. Bowen, Amy W. Chung, Marc Pellegrini, Mark T. Liddament, Alisa Glukhova, Kanta Subbarao, Stephen J. Kent, Wai-Hong Tham |
| 195 |
[GO] |
2021―Sep―21 |
A highly potent antibody effective against SARS-CoV-2 variants of concern |
Craig Fenwick, Priscilla Turelli, Laurent Perez, Céline Pellaton, Line Esteves-Leuenberger, Alex Farina, Jérémy Campos, Erica Lana, Flurin Fiscalini, Charlène Raclot, Florence Pojer, Kelvin Lau, Demurtas Davide, Marc Descatoire, Victor S. Joo, Mathilde Foglierini, Alessandra Noto, Rana Abdelnabi, Caroline S. Foo, Laura Vangeel, Johan Neyts, Wenjuan Du, Berend-Jan Bosch, Geertruida Veldman, Pieter Leyssen, Volker Thiel, Roger LeGrand, Yves Lévy, Didier Trono, Giuseppe Pantaleo |
| 196 |
[GO] |
2021―Sep―20 |
Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19 |
Dong-Min Kim, Yuri Kim, Jun-Won Seo, Jooyeon Lee, Uni Park, Na-Young Ha, Jaemoon Koh, Hyoree Park, Jae-Won Lee, Hyo-Jin Ro, Na Ra Yun, Da Young Kim, Sung Ho Yoon, Yong Sub Na, Do Sik Moon, Sung-Chul Lim, Choon-Mee Kim, Kyeongseok Jeon, Jun-Gu Kang, Na-Yoon Jang, Hyeongseok Jeong, Jungok Kim, Shinhyea Cheon, Kyung Mok Sohn, Jae Youg Moon, Sungmin Kym, Seung Ro Han, Myung-Shin Lee, Hyun-Je Kim, Woong-Yang Park, Ji-Yeob Choi, Hyun-Woo Shin, Hye-Young Kim, Chung-Hyun Cho, Yoon Kyung Jeon, Yeon-Sook Kim, Nam-Hyuk Cho |
| 197 |
[GO] |
2021―Sep―17 |
Single-cell analysis of COVID-19, sepsis, and HIV infection reveals hyperinflammatory and immunosuppressive signatures in monocytes |
Nianping Liu, Chen Jiang, Pengfei Cai, Zhuoqiao Shen, Wujianan Sun, Hao Xu, Minghao Fang, Xinfeng Yao, Lin Zhu, Xuyuan Gao, Jingwen Fang, Jun Lin, Chuang Guo, Kun Qu |
| 198 |
[GO] |
2021―Sep―16 |
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition |
Kevin J. Kramer, Nicole V. Johnson, Andrea R. Shiakolas, Naveenchandra Suryadevara, Sivakumar Periasamy, Nagarajan Raju, Jazmean K. Williams, Daniel Wrapp, Seth J. Zost, Lauren M. Walker, Steven C. Wall, Clinton M. Holt, Ching-Lin Hsieh, Rachel E. Sutton, Ariana Paulo, Edgar Davidson, Benjamin J. Doranz, James E. Crowe, Alexander Bukreyev, Robert H. Carnahan, Jason S. McLellan, Ivelin S. Georgiev |
| 199 |
[GO] |
2021―Sep―15 |
Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity |
Maria Vono, Angela Huttner, Sylvain Lemeille, Paola Martinez-Murillo, Benjamin Meyer, Stephanie Baggio, Shilpee Sharma, Anais Thiriard, Arnaud Marchant, Gert-Jan Godeke, Chantal Reusken, Catia Alvarez, Francisco Perez-Rodriguez, Isabella Eckerle, Laurent Kaiser, Natasha Loevy, Christiane S. Eberhardt, Geraldine Blanchard-Rohner, Claire-Anne Siegrist, Arnaud M. Didierlaurent |
| 200 |
[GO] |
2021―Sep―08 |
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies |
Claudia A. Jette, Alexander A. Cohen, Priyanthi N.P. Gnanapragasam, Frauke Muecksch, Yu E. Lee, Kathryn E. Huey-Tubman, Fabian Schmidt, Theodora Hatziioannou, Paul D. Bieniasz, Michel C. Nussenzweig, Anthony P. West, Jennifer R. Keeffe, Pamela J. Bjorkman, Christopher O. Barnes |
| 201 |
[GO] |
2021―Sep―08 |
A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease |
Stephanie Patchett, Zongyang Lv, Wioletta Rut, Miklos Bekes, Marcin Drag, Shaun K. Olsen, Tony T. Huang |
| 202 |
[GO] |
2021―Aug―27 |
Profiling CD8+ T Cell Epitopes of COVID-19 Convalescents Reveals Reduced Cellular Immune Responses to SARS-CoV-2 Variants |
Hang Zhang, Shasha Deng, Liting Ren, Peiyi Zheng, Xiaowen Hu, Tengchuan Jin, Xu Tan |
| 203 |
[GO] |
2021―Aug―17 |
Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2 |
Tanushree Dangi, Jacob Class, Nicole Palacio, Justin M. Richner, Pablo Penaloza-MacMaster |
| 204 |
[GO] |
2021―Aug―17 |
The nucleotide addition cycle of the SARS-CoV-2 polymerase |
Subhas Chandra Bera, Mona Seifert, Robert N. Kirchdoerfer, Pauline van Nies, Yibulayin Wubulikasimu, Salina Quack, Flávia S. Papini, Jamie J. Arnold, Bruno Canard, Craig E. Cameron, Martin Depken, David Dulin |
| 205 |
[GO] |
2021―Aug―13 |
Acute SARS-CoV-2 infection is associated with an increased abundance of bacterial pathogens, including Pseudomonas aeruginosa in the nose |
Nicholas S. Rhoades, Amanda N. Pinski, Alisha N. Monsibais, Allen Jankeel, Brianna M. Doratt, Isaac R. Cinco, Izabela Ibraim, Ilhem Messaoudi |
| 206 |
[GO] |
2021―Aug―10 |
One-shot identification of SARS-CoV-2 S RBD escape mutants using yeast screening |
Irene M. Francino-Urdaniz, Paul J. Steiner, Monica B. Kirby, Fangzhu Zhao, Cyrus M. Haas, Shawn Barman, Emily R. Rhodes, Alison C. Leonard, Linghang Peng, Kayla G. Sprenger, Joseph G. Jardine, Timothy A. Whitehead |
| 207 |
[GO] |
2021―Aug―10 |
Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals |
Elaine C. Chen, Pavlo Gilchuk, Seth J. Zost, Naveenchandra Suryadevara, Emma S. Winkler, Carly R. Cabel, Elad Binshtein, Rita Chen, Rachel E. Sutton, Jessica Rodriguez, Samuel Day, Luke Myers, Andrew Trivette, Jazmean K. Williams, Edgar Davidson, Shuaizhi Li, Benjamin J. Doranz, Samuel K. Campos, Robert H. Carnahan, Curtis A. Thorne, Michael S. Diamond, James E. Crowe |
| 208 |
[GO] |
2021―Aug―06 |
Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms |
Michael J. Peluso, Amelia N. Deitchman, Leonel Torres, Nikita S. Iyer, Sadie E. Munter, Christopher C. Nixon, Joanna Donatelli, Cassandra Thanh, Saki Takahashi, Jill Hakim, Keirstinne Turcios, Owen Janson, Rebecca Hoh, Viva Tai, Yanel Hernandez, Emily A. Fehrman, Matthew A. Spinelli, Monica Gandhi, Lan Trinh, Terri Wrin, Christos J. Petropoulos, Francesca T. Aweeka, Isabel Rodriguez-Barraquer, J. Daniel Kelly, Jeffrey N. Martin, Steven G. Deeks, Bryan Greenhouse, Rachel L. Rutishauser, Timothy J. Henrich |
| 209 |
[GO] |
2021―Aug―04 |
Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naïve and COVID-19 recovered individuals |
Daniel Lozano-Ojalvo, Carmen Camara, Eduardo Lopez-Granados, Pilar Nozal, Lucía del Pino-Molina, Yadira Bravo-Gallego, Estela Paz-Artal, Marjorie Pion, Rafael Correa-Rocha, Alberto Ortiz, Marcos Lopez-Hoyos, Marta Erro Iribarren, Jose Portoles, Maria Pilar Rojo-Portoles, Gloria Ojeda, Isabel Cervera, Maria Gonzalez-Perez, Irene Bodega-Mayor, Maria Montes-Casado, Pilar Portoles, Mayte Perez-Olmeda, Jesus Oteo, Rodrigo Sanchez-Tarjuelo, Venu Pothula, Megan Schwarz, Manisha Brahmachary, Anthony Tanoto Tan, Nina Le Bert, Cecilia Berin, Antonio Bertoletti, Ernesto Guccione, Jordi Ochando |
| 210 |
[GO] |
2021―Jul―28 |
No evidence of human genome integration of SARS-CoV-2 found by long-read DNA sequencing |
Nathan Smits, Jay Rasmussen, Gabriela O. Bodea, Alberto A. Amarilla, Patricia Gerdes, Francisco J. Sanchez-Luque, Prabha Ajjikuttira, Naphak Modhiran, Benjamin Liang, Jamila Faivre, Ira W. Deveson, Alexander A. Khromykh, Daniel Watterson, Adam D. Ewing, Geoffrey J. Faulkner |
| 211 |
[GO] |
2021―Jul―23 |
Systemic IL-15, IFN-γ and IP-10/CXCL10 Signature Associated with Effective Immune Response to SARS-CoV-2 in BNT162b2 mRNA Vaccine Recipients |
Cristina Bergamaschi, Evangelos Terpos, Margherita Rosati, Matthew Angel, Jenifer Bear, Dimitris Stellas, Sevasti Karaliota, Filia Apostolakou, Tina Bagratuni, Dimitris Patseas, Sentiljana Gumeni, Ioannis P. Trougakos, Meletios A. Dimopoulos, Barbara K. Felber, George N. Pavlakis |
| 212 |
[GO] |
2021―Jul―20 |
Inhibitors of VPS34 and fatty-acid metabolism suppress SARS-CoV-2 replication |
Caroline G. Williams, Alexander S. Jureka, Jesus A. Silvas, Anthony M. Nicolini, Stacie A. Chvatal, Jared Carlson-Stevermer, Jennifer Oki, Kevin Holden, Christopher F. Basler |
| 213 |
[GO] |
2021―Jul―20 |
Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding |
Jakob Trimpert, Kristina Dietert, Theresa C. Firsching, Nadine Ebert, Tran Thi Nhu Thao, Daria Vladimirova, Susanne Kaufer, Fabien Labroussaa, Azza Abdelgawad, Andelé Conradie, Thomas Höfler, Julia M. Adler, Luca D. Bertzbach, Joerg Jores, Achim D. Gruber, Volker Thiel, Nikolaus Osterrieder, Dusan Kunec |
| 214 |
[GO] |
2021―Jul―17 |
Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome |
Weifan Xu, Gaofeng Pei, Hongrui Liu, Xiaohui Ju, Jing Wang, Qiang Ding, Pilong Li |
| 215 |
[GO] |
2021―Jul―10 |
Prevention and therapy of SARS-CoV-2 and the B.1.351 variant in mice |
David R. Martinez, Alexandra Scha¨fer, Sarah R. Leist, Dapeng Li, Kendra Gully, Boyd Yount, Joy Y. Feng, Elaine Bunyan, Danielle P. Porter, Tomas Cihlar, Stephanie A. Montgomery, Barton F. Haynes, Ralph S. Baric, Michel C. Nussenzweig, Timothy P. Sheahan |
| 216 |
[GO] |
2021―Jul―10 |
An intranasal vaccine durably protects against SARS-CoV-2 variants in mice |
Ahmed O. Hassan, Swathi Shrihari, Matthew J. Gorman, Baoling Ying, Dansu Yaun, Saravanan Raju, Rita E. Chen, Igor P. Dmitriev, Elena Kashentseva, Lucas J. Adams, Colin Mann, Meredith E. Davis-Gardner, Mehul S. Suthar, Pei-Yong Shi, Erica Ollmann Saphire, Daved H. Fremont, David T. Curiel, Galit Alter, Michael S. Diamond |
| 217 |
[GO] |
2021―Jul―07 |
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations |
Federico Bertoglio, Viola Fühner, Maximilian Ruschig, Philip Alexander Heine, Leila Abassi, Thomas Klünemann, Ulfert Rand, Doris Meier, Nora Langreder, Stephan Steinke, Rico Ballmann, Kai-Thomas Schneider, Kristian Daniel Ralph Roth, Philipp Kuhn, Peggy Riese, Dorina Schäckermann, Janin Korn, Allan Koch, M. Zeeshan Chaudhry, Kathrin Eschke, Yeonsu Kim, Susanne Zock-Emmenthal, Marlies Becker, Margitta Scholz, Gustavo Marçal Schmidt Garcia Moreira, Esther Veronika Wenzel, Giulio Russo, Hendrikus S.P. Garritsen, Sebastian Casu, Andreas Gerstner, Günter Roth, Julia Adler, Jakob Trimpert, Andreas Hermann, Thomas Schirrmann, Stefan Dübel, André Frenzel, Joop Van den Heuvel, Luka Čičin-Šain, Maren Schubert, Michael Hust |
| 218 |
[GO] |
2021―Jul―07 |
Generation of glucocorticoid resistant SARS-CoV-2 T-cells for adoptive cell therapy |
Rafet Basar, Nadima Uprety, Emily Ensley, May Daher, Kimberly Klein, Fernando Martinez, Fleur Aung, Mayra Shanley, Bingqian Hu, Elif Gokdemir, Ana Karen Nunez Cortes, Mayela Mendt, Francia Reyes Silva, Sunil Acharya, Tamara Laskowski, Luis Muniz-Feliciano, Pinaki P. Banerjee, Ye Li, Sufang Li, Luciana Melo Garcia, Paul Lin, Hila Shaim, Sean G. Yates, David Marin, Indreshpal Kaur, Sheetal Rao, Duncan Mak, Angelique Lin, Qi Miao, Jinzhuang Dou, Ken Chen, Richard E. Champlin, Elizabeth J. Shpall, Katayoun Rezvani |
| 219 |
[GO] |
2021―Jun―29 |
Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19 |
Jason Neidleman, Xiaoyu Luo, Ashley F. George, Matthew McGregor, Junkai Yang, Cassandra Yun, Victoria Murray, Gurjot Gill, Warner C. Greene, Joshua Vasquez, Sulggi A. Lee, Eliver Ghosn, Kara Lynch, Nadia R. Roan |
| 220 |
[GO] |
2021―Jun―29 |
A single intranasal or intramuscular immunization with chimpanzee adenovirus vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters |
Traci L. Bricker, Tamarand L. Darling, Ahmed O. Hassan, Houda H. Harastani, Allison Soung, Xiaoping Jiang, Ya-Nan Dai, Haiyan Zhao, Lucas J. Adams, Michael J. Holtzman, Adam L. Bailey, James Brett Case, Daved H. Fremont, Robyn Klein, Michael S. Diamond, Adrianus C.M. Boon |
| 221 |
[GO] |
2021―Jun―29 |
SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination |
Markus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, Amy Kempf, Inga Nehlmeier, Luise Graichen, Prerna Arora, Anzhalika Sidarovich, Anna-Sophie Moldenhauer, Martin S. Winkler, Sebastian Schulz, Hans-Martin Jäck, Metodi V. Stankov, Georg M.N. Behrens, Stefan Pöhlmann |
| 222 |
[GO] |
2021―Jun―26 |
Antibody landscape against SARS-CoV-2 proteome reveals significant differences between non-structural/ accessory proteins and structural proteins |
Yang Li, Zhaowei Xu, Qing Lei, Dan-yun Lai, Hongyan Hou, He-wei Jiang, Yun-xiao Zheng, Xue-ning Wang, Jiaoxiang Wu, Ming-liang Ma, Bo Zhang, Hong Chen, Caizheng Yu, Jun-biao Xue, Hai-nan Zhang, Huan Qi, Shu-juan Guo, Yandi Zhang, Xiaosong Lin, Zongjie Yao, Huiming Sheng, Ziyong Sun, Feng Wang, Xionglin Fan, Sheng-ce Tao |
| 223 |
[GO] |
2021―Jun―25 |
Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19 |
Yu Kaku, Takeo Kuwata, Hasan Md Zahid, Takao Hashiguchi, Takeshi Noda, Noriko Kuramoto, Shashwata Biswas, Kaho Matsumoto, Mikiko Shimizu, Yoko Kawanami, Kazuya Shimura, Chiho Onishi, Yukiko Muramoto, Tateki Suzuki, Jiei Sasaki, Yoji Nagasaki, Rumi Minami, Chihiro Motozono, Mako Toyoda, Hiroshi Takahashi, Hiroto Kishi, Kazuhiko Fujii, Tsuneyuki Tatsuke, Terumasa Ikeda, Maeda Yosuke, Takamasa Ueno, Yoshio Koyanagi, Hajime Iwagoe, Shuzo Matsushita |
| 224 |
[GO] |
2021―Jun―23 |
Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell |
Maritza Puray-Chavez, Kyle M. LaPak, Travis P. Schrank, Jennifer L. Elliott, Dhaval P. Bhatt, Megan J. Agajanian, Ria Jasuja, Dana Q. Lawson, Keanu Davis, Paul W. Rothlauf, Zhuoming Liu, Heejoon Jo, Nakyung Lee, Kasyap Tenneti, Jenna E. Eschbach, Christian Shema Mugisha, Emily M. Cousins, Erica W. Cloer, Hung R. Vuong, Laura A. VanBlargan, Adam L. Bailey, Pavlo Gilchuk, James E. Crowe, Michael S. Diamond, D. Neil Hayes, Sean P.J. Whelan, Amjad Horani, Steven L. Brody, Dennis Goldfarb, M. Ben Major, Sebla B. Kutluay |
| 225 |
[GO] |
2021―Jun―22 |
Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects |
Madeleine F. Jennewein, Anna J. MacCamy, Nicholas R. Akins, Junli Feng, Leah J. Homad, Nicholas K. Hurlburt, Emilie Seydoux, Yu-Hsin Wan, Andrew B. Stuart, Venkata Viswanadh Edara, Katharine Floyd, Abigail Vanderheiden, John R. Mascola, Nicole Doria-Rose, Lingshu Wang, Eun Sung Yang, Helen Y. Chu, Jonathan L. Torres, Gabriel Ozorowski, Andrew B. Ward, Rachael E. Whaley, Kristen W. Cohen, Marie Pancera, M. Juliana McElrath, Janet A. Englund, Andrés Finzi, Mehul S. Suthar, Andrew T. McGuire, Leonidas Stamatatos |
| 226 |
[GO] |
2021―Jun―11 |
Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4+ T cell help |
Jernej Pušnik, Enrico Richter, Bianca Schulte, Ramona Dolscheid-Pommerich, Christian Bode, Christian Putensen, Gunther Hartmann, Galit Alter, Hendrik Streeck |
| 227 |
[GO] |
2021―Jun―08 |
Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA-peptidomics |
Adi Nagler, Shelly Kalaora, Chaya Barbolin, Anastasia Gangaev, Steven L.C. Ketelaars, Michal Alon, Joy Pai, Gil Benedek, Yfat Yahalom-Ronen, Noam Erez, Polina Greenberg, Gal Yagel, Aviyah Peri, Yishai Levin, Ansuman T. Satpathy, Erez Bar-Haim, Nir Paran, Pia Kvistborg, Yardena Samuels |
| 228 |
[GO] |
2021―Jun―08 |
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the variant of concern lineage B.1.1.7 |
Bo Meng, Steven A. Kemp, Guido Papa, Rawlings Datir, Isabella ATM. Ferreira, Sara Marelli, William T. Harvey, Spyros Lytras, Ahmed Mohamed, Giulia Gallo, Nazia Thakur, Dami A. Collier, Petra Mlcochova, Lidia M. Duncan, Alessandro M. Carabelli, Julia C. Kenyon, Andrew M. Lever, Anna De Marco, Christian Saliba, Katja Culap, Elisabetta Cameroni, Nicholas J. Matheson, Luca Piccoli, Davide Corti, Leo C. James, David L. Robertson, Dalan Bailey, Ravindra K. Gupta |
| 229 |
[GO] |
2021―Mai―19 |
Direct Derivation of Human Alveolospheres for SARS-CoV-2 Infection Modeling and Drug Screening |
Toshiki Ebisudani, Shinya Sugimoto, Kei Haga, Akifumi Mitsuishi, Reiko Takai-Todaka, Masayuki Fujii, Kohta Toshimitsu, Junko Hamamoto, Kai Sugihara, Tomoyuki Hishida, Hisao Asamura, Koichi Fukunaga, Hiroyuki Yasuda, Kazuhiko Katayama, Toshiro Sato |
| 230 |
[GO] |
2021―Mai―14 |
SARS-CoV-2 genomic surveillance identifies naturally occurring truncation of ORF7a that limits immune suppression. |
Artem Nemudryi, Anna Nemudraia, Tanner Wiegand, Joseph Nichols, Deann T. Snyder, Jodi F. Hedges, Calvin Cicha, Helen Lee, Karl K. Vanderwood, Diane Bimczok, Mark A. Jutila, Blake Wiedenheft |
| 231 |
[GO] |
2021―Mai―13 |
Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells |
Robert Parker, Thomas Partridge, Catherine Wormald, Rebeca Kawahara, Victoria Stalls, Maria Aggelakopoulou, Jimmy Parker, Rebecca Powell Doherty, Yoanna Ariosa Morejon, Esther Lee, Kevin Saunders, Barton F. Haynes, Priyamvada Acharya, Morten Thaysen-Andersen, Persephone Borrow, Nicola Ternette |
| 232 |
[GO] |
2021―Mai―09 |
Dynamics of B-cell repertoires and emergence of cross-reactive responses in patients with different severities of COVID-19 |
Zachary Montague, Huibin Lv, Jakub Otwinowski, William S. DeWitt, Giulio Isacchini, Garrick K. Yip, Wilson W. Ng, Owen Tak-Yin Tsang, Meng Yuan, Hejun Liu, Ian A. Wilson, J. S. Malik Peiris, Nicholas C. Wu, Armita Nourmohammad, Chris Ka Pun Mok |
| 233 |
[GO] |
2021―Mai―03 |
METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection |
Na Li, Hui Hui, Bill Bray, Gwendolyn Michelle Gonzalez, Mark Zeller, Kristian G. Anderson, Rob Knight, Davey Smith, Yinsheng Wang, Aaron F. Carlin, Tariq M. Rana |
| 234 |
[GO] |
2021―Apr―27 |
Hepatitis C Virus Drugs That Inhibit the SARS-CoV-2 Papain-Like Protease Synergize with Remdesivir to Suppress Viral Replication in Cell Culture |
Khushboo Bafna, Kris White, Balasubramanian Harish, Romel Rosales, Theresa A. Ramelot, Thomas B. Acton, Elena Moreno, Thomas Kehrer, Lisa Miorin, Catherine A. Royer, Adolfo García-Sastre, Robert M. Krug, Gaetano T. Montelione |
| 235 |
[GO] |
2021―Apr―27 |
Systematic Functional Analysis of SARS-CoV-2 Proteins Uncovers Viral Innate Immune Antagonists and Remaining Vulnerabilities |
Manuel Hayn, Maximilian Hirschenberger, Lennart Koepke, Rayhane Nchioua, Jan Hendrik Straub, Susanne Klute, Victoria Hunszinger, Fabian Zech, Caterina Prelli Bozzo, Wasim Aftab, Maria Hønholt Christensen, Carina Conzelmann, Janis Alexander Müller, Smitha Srinivasachar Badarinarayan, Christina Martina Stürzel, Ignasi Forne, Steffen Stenger, Karl-Klaus Conzelmann, Jan Münch, Florian Ingo Schmidt, Daniel Sauter, Axel Imhof, Frank Kirchhoff, Konstantin Maria Johannes Sparrer |
| 236 |
[GO] |
2021―Apr―24 |
Diverse immunoglobulin gene usage and convergent epitope targeting in neutralizing antibody responses to SARS-CoV-2 |
Xiaojuan Zhou, Fengge Ma, Jun Xie, Meng Yuan, Yunqiao Li, Namir Shaabani, Fangzhu Zhao, Deli Huang, Nicholas C. Wu, Chang-Chun D. Lee, Hejun Liu, Jiali Li, Zhonghui Chen, Yazhen Hong, Wen-Hsien Liu, Nengming Xiao, Dennis R. Burton, Haijian Tu, Hang Li, Xin Chen, John R. Teijaro, Ian A. Wilson, Changchun Xiao, Zhe Huang |
| 237 |
[GO] |
2021―Apr―23 |
Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection |
Jessie J.-Y. Chang, Daniel Rawlinson, Miranda E. Pitt, George Taiaroa, Josie Gleeson, Chenxi Zhou, Francesca L. Mordant, Ricardo De Paoli-Iseppi, Leon Caly, Damian F.J. Purcell, Tim P. Stinear, Sarah L. Londrigan, Michael B. Clark, Deborah A. Williamson, Kanta Subbarao, Lachlan J.M. Coin |
| 238 |
[GO] |
2021―Apr―15 |
SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery |
Apoorva Mulay, Bindu Konda, Gustavo Garcia, Changfu Yao, Stephen Beil, Jaquelyn Mary Villalba, Colin Koziol, Chandani Sen, Arunima Purkayastha, Jay.K. Kolls, Derek.A. Pociask, Patrizia Pessina, Julio Sainz de Aja, Carolina Garcia-de-Alba, Carla F. Kim, Brigitte Gomperts, Vaithilingaraja Arumugaswami, Barry R. Stripp |
| 239 |
[GO] |
2021―Apr―05 |
Hypoxic and pharmacological activation of HIFs inhibits SARS-CoV-2 infection of lung epithelial cells |
Peter AC. Wing, Thomas P. Keeley, Xiaodong Zhuang, Jeffrey Y. Lee, Maria Prange-Barczynska, Senko Tsukuda, Sophie B. Morgan, Adam C. Harding, Isobel L.A. Argles, Samvid Kurlekar, Marko Noerenberg, Craig P. Thompson, Kuan-Ying A Huang, Peter Balfe, Koichi Watashi, Alfredo Castello, Timothy SC. Hinks, William James, Peter J. Ratcliffe, Ilan Davis, Emma J. Hodson, Tammie Bishop, Jane A. McKeating |
| 240 |
[GO] |
2021―Apr―03 |
SARS-CoV-2 mutations acquired in mink reduce antibody-mediated neutralization |
Markus Hoffmann, Lu Zhang, Nadine Krüger, Luise Graichen, Hannah Kleine-Weber, Heike Hofmann-Winkler, Amy Kempf, Stefan Nessler, Joachim Riggert, Martin Sebastian Winkler, Sebastian Schulz, Hans-Martin Jäck, Stefan Pöhlmann |
| 241 |
[GO] |
2021―Apr―02 |
Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction |
Shiho Torii, Chikako Ono, Rigel Suzuki, Yuhei Morioka, Itsuki Anzai, Yuzy Fauzyah, Maeda Yusuke, Wataru Kamitani, Takasuke Fukuhara, Yoshiharu Matsuura |
| 242 |
[GO] |
2021―Mrz―31 |
Cell-type-specific immune dysregulation in severely ill COVID-19 patients |
Changfu Yao, Stephanie A. Bora, Tanyalak Parimon, Tanzira Zaman, Oren A. Friedman, Joseph A. Palatinus, Nirmala S. Surapaneni, Yuri P. Matusov, Giuliana Cerro Chiang, Alexander G. Kassar, Nayan Patel, Chelsi E.R. Green, Adam W. Aziz, Harshpreet Suri, Jo Suda, Andres A. Lopez, Gislâine A. Martins, Barry R. Stripp, Sina A. Gharib, Helen S. Goodridge, Peter Chen |
| 243 |
[GO] |
2021―Mrz―23 |
Drug repurposing screens reveal cell-type specific entry pathways and FDA approved drugs active against SARS-Cov-2 |
Mark Dittmar, Jae Seung Lee, Kanupriya Whig, Elisha Segrist, Minghua Li, Brinda Kamalia, Lauren Castellana, Kasirajan Ayyanathan, Rachel Truitt, Wenli Yang, Kellie Jurado, Kirandeep Samby, Holly Ramage, David C. Schultz, Sara Cherry |
| 244 |
[GO] |
2021―Mrz―20 |
Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class |
Micah Rapp, Yicheng Guo, Eswar R. Reddem, Jian Yu, Lihong Liu, Pengfei Wang, Gabriele Cerutti, Phinikoula Katsamba, Jude S. Bimela, Fabiana A. Bahna, Seetha M. Mannepalli, Baoshan Zhang, Peter D. Kwong, Yaoxing Huang, David D. Ho, Lawrence Shapiro, Zizhang Sheng |
| 245 |
[GO] |
2021―Mrz―19 |
Antiviral Drug Screen Identifies DNA-Damage Response Inhibitor as Potent Blocker of SARS-CoV-2 Replication |
Gustavo Garcia, Arun Sharma, Arunachalam Ramaiah, Chandani Sen, Arunima Purkayastha, Donald B. Kohn, Mark S. Parcells, Sebastian Beck, Heeyoung Kim, Malina A. Bakowski, Melanie G. Kirkpatrick, Laura Riva, Karen C. Wolff, Brandon Han, Constance Yuen, David Ulmert, Prabhat K. Purbey, Phillip Scumpia, Nathan Beutler, Thomas F. Rogers, Arnab K. Chatterjee, Gülsah Gabriel, Ralf Bartenschlager, Brigitte Gomperts, Clive N. Svendsen, Ulrich A.K. Betz, Robert D. Damoiseaux, Vaithilingaraja Arumugaswami |
| 246 |
[GO] |
2021―Mrz―18 |
Virological and immunological features of SARS-CoV-2-infected children who develop neutralizing antibodies |
Nicola Cotugno, Alessandra Ruggiero, Francesco Bonfante, Maria Raffaella Petrara, Sonia Zicari, Giuseppe Rubens Pascucci, Paola Zangari, Maria Antonietta De Ioris, Veronica Santilli, E.C. Manno, Donato Amodio, Alessio Bortolami, Matteo Pagliari, Carlo Concato, Giulia Linardos, Andrea Campana, Daniele Donà, Carlo Giaquinto, Petter Brodin, Paolo Rossi, Anita De Rossi, Paolo Palma, Stefania Bernardi, Lorenza Romani, Paola Pansa, Sara Chiurchiú, Andrea Finocchi, Caterina Cancrini, Laura Lancella, Laura Cursi, Maia De Luca, Renato Cutrera, Libera Sessa, Elena Morrocchi, Chiara Medri, Lorenza Putignani, F.I. Calò Carducci, Patrizia D’Argenio, Marta Ciofi degli Atti, Carmen D’Amore, Livia Piccioni, Martina Di Giuseppe, Alessandro Jenkner, Carmela Giancotta, Andrzej Krzysztofiak |
| 247 |
[GO] |
2021―Mrz―14 |
Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients |
Yang Li, Ming-liang Ma, Qing Lei, Feng Wang, Wei Hong, Dan-yun Lai, Hongyan Hou, Zhao-wei Xu, Bo Zhang, Hong Chen, Caizheng Yu, Jun-biao Xue, Yun-xiao Zheng, Xue-ning Wang, He-wei Jiang, Hai-nan Zhang, Huan Qi, Shu-juan Guo, Yandi Zhang, Xiaosong Lin, Zongjie Yao, Jiaoxiang Wu, Huiming Sheng, Yanan Zhang, Hongping Wei, Ziyong Sun, Xionglin Fan, Sheng-ce Tao |
| 248 |
[GO] |
2021―Mrz―07 |
The impact of Spike mutations on SARS-CoV-2 neutralization |
Chloe Rees-Spear, Luke Muir, Sarah A. Griffith, Judith Heaney, Yoann Aldon, Jonne L. Snitselaar, Peter Thomas, Carl Graham, Jeffrey Seow, Nayung Lee, Annachiara Rosa, Chloe Roustan, Catherine F. Houlihan, Rogier W. Sanders, Ravindra K. Gupta, Peter Cherepanov, Hans J. Stauss, Eleni Nastouli, Katie J. Doores, Marit J. van Gils, Laura E. McCoy |
| 249 |
[GO] |
2021―Feb―26 |
Metabolic programs define dysfunctional immune responses in severe COVID-19 patients |
Elizabeth A. Thompson, Katherine Cascino, Alvaro A. Ordonez, Weiqiang Zhou, Ajay Vaghasia, Anne Hamacher-Brady, Nathan R. Brady, Im-Hong Sun, Rulin Wang, Avi Z. Rosenberg, Michael Delannoy, Richard Rothman, Katherine Fenstermacher, Lauren Sauer, Kathyrn Shaw-Saliba, Evan M. Bloch, Andrew D. Redd, Aaron AR. Tobian, Maureen Horton, Kellie Smith, Andrew Pekosz, Franco R. D’Alessio, Srinivasan Yegnasubramanian, Hongkai Ji, Andrea L. Cox, Jonathan D. Powell |
| 250 |
[GO] |
2021―Feb―23 |
Use of convalescent serum reduces severity of COVID-19 in nonhuman primates |
Robert W. Cross, Abhishek N. Prasad, Viktoriya Borisevich, Courtney Woolsey, Krystle N. Agans, Daniel J. Deer, Natalie S. Dobias, Joan B. Geisbert, Karla A. Fenton, Thomas W. Geisbert |
| 251 |
[GO] |
2021―Feb―10 |
Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2 |
Romain Gasser, Marc Cloutier, Jérémie Prévost, Corby Fink, Éric Ducas, Shilei Ding, Nathalie Dussault, Patricia Landry, Tony Tremblay, Audrey Laforce-Lavoie, Antoine Lewin, Guillaume Beaudoin-Bussières, Annemarie Laumaea, Halima Medjahed, Catherine Larochelle, Jonathan Richard, Gregory A. Dekaban, Jimmy D. Dikeakos, Renée Bazin, Andrés Finzi |
| 252 |
[GO] |
2021―Feb―05 |
SARS-CoV-2 ORF9b Inhibits RIG-I-MAVS Antiviral Signaling by Interrupting K63-Linked Ubiquitination of NEMO |
Jing Wu, Yuheng Shi, Xiaoyan Pan, Shuang Wu, Ruixia Hou, Yong Zhang, Tiansheng Zhong, Hao Tang, Wei Du, Luying Wang, Jing Wo, Jingfang Mu, Yang Qiu, Ke Yang, Lei-Ke Zhang, Bang-Ce Ye, Nan Qi |
| 253 |
[GO] |
2021―Jan―26 |
Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2 |
Timothy A. Bates, Jules B. Weinstein, Scotland Farley, Hans C. Leier, William B. Messer, Fikadu G. Tafesse |
| 254 |
[GO] |
2021―Jan―26 |
The immunodominant and neutralization linear epitopes for SARS-CoV-2 |
Shuai Lu, Xi-xiu Xie, Lei Zhao, Bin Wang, Jie Zhu, Ting-rui Yang, Guang-wen Yang, Mei Ji, Cui-ping Lv, Jian Xue, Er-hei Dai, Xi-ming Fu, Dong-qun Liu, Lun Zhang, Sheng-jie Hou, Xiao-lin Yu, Yu-ling Wang, Hui-xia Gao, Xue-han Shi, Chang-wen Ke, Bi-xia Ke, Chun-guo Jiang, Rui-tian Liu |
| 255 |
[GO] |
2021―Jan―22 |
Early induction of functional SARS-CoV-2 specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients |
Anthony T. Tan, Martin Linster, Chee Wah Tan, Nina Le Bert, Wan Ni Chia, Kamini Kunasegaran, Yan Zhuang, Christine Y.L. Tham, Adeline Chia, Gavin JD. Smith, Barnaby Young, Shirin Kalimuddin, Jenny G.H. Low, David Lye, Lin-Fa Wang, Antonio Bertoletti |
| 256 |
[GO] |
2021―Jan―14 |
MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells |
Xin Yin, Laura Riva, Yuan Pu, Laura Martin-Sancho, Jun Kanamune, Yuki Yamamoto, Kouji Sakai, Shimpei Gotoh, Lisa Miorin, Paul D. De Jesus, Chih-Cheng Yang, Kristina M. Herbert, Sunnie Yoh, Judd F. Hultquist, Adolfo García-Sastre, Sumit K. Chanda |
| 257 |
[GO] |
2021―Jan―14 |
Enhancement versus Neutralization by SARS-CoV-2 Antibodies from A Convalescent Donor Associates with Distinct Epitopes on the Receptor-Binding Domain |
Yunjiao Zhou, Zezhong Liu, Shibo Li, Wei Xu, Qianqian Zhang, Israel T. Silva, Cheng Li, Yanling Wu, Qingling Jiang, Zhenmi Liu, Qiujing Wang, Yu Guo, Jianbo Wu, Chengjian Gu, Xia Cai, Di Qu, Christian T. Mayer, Xiangxi Wang, Shibo Jiang, Tianlei Ying, Zhenghong Yuan, Youhua Xie, Yumei Wen, Lu Lu, Qiao Wang |
| 258 |
[GO] |
2020―Dez―26 |
D614G mutation alters SARS-CoV-2 spike conformation and enhances protease cleavage at the S1/S2 junction |
Sophie M-C. Gobeil, Katarzyna Janowska, Shana McDowell, Katayoun Mansouri, Robert Parks, Kartik Manne, Victoria Stalls, Megan F. Kopp, Rory Henderson, Robert J. Edwards, Barton F. Haynes, Priyamvada Acharya |
| 259 |
[GO] |
2020―Dez―17 |
Cell type-specific immune dysregulation in severely ill COVID-19 patients |
Changfu Yao, Stephanie A. Bora, Tanyalak Parimon, Tanzira Zaman, Oren A. Friedman, Joseph A. Palatinus, Nirmala S. Surapaneni, Yuri P. Matusov, Giuliana Cerro Chiang, Alexander G. Kassar, Nayan Patel, Chelsi ER. Green, Adam W. Aziz, Harshpreet Suri, Jo Suda, Andres A. Lopez, Gislâine A. Martins, Barry R. Stripp, Sina A. Gharib, Helen S. Goodridge, Peter Chen |
| 260 |
[GO] |
2020―Dez―01 |
A soluble ACE2 microbody protein fused to a single immunoglobulin Fc domain is a potent inhibitor of SARS-CoV-2 |
Takuya Tada, Chen Fan, Jennifer S. Chen, Ramanjit Kaur, Kenneth A. Stapleford, Harry Gristick, Belinda M. Dcosta, Craig B. Wilen, Crina M. Nimigean, Nathaniel R. Landau |
| 261 |
[GO] |
2020―Nov―19 |
The Roborovski dwarf hamster - a highly susceptible model for a rapid and fatal course of SARS-CoV-2 infection |
Jakob Trimpert, Daria Vladimirova, Kristina Dietert, Azza Abdelgawad, Dusan Kunec, Simon Dökel, Anne Voss, Achim D. Gruber, Luca D. Bertzbach, Nikolaus Osterrieder |
| 262 |
[GO] |
2020―Nov―13 |
The Human Leukocyte Antigen Class II Immunopeptidome of SARS-CoV-2 Spike Glycoprotein |
Michael D. Knierman, Megan B. Lannan, Laura J. Spindler, Carl L. McMillian, Robert J. Konrad, Robert W. Siegel |
| 263 |
[GO] |
2020―Nov―03 |
HSV-1 and Zika Virus but Not SARS-CoV-2 Replicate in the Human Cornea and Are Restricted by Corneal Type III Interferon |
Jonathan J. Miner, Derek J. Platt, Cyrus M. Ghaznavi, Pallavi Chandra, Andrea Santeford, Amber M. Menos, Zhenyu Dong, Erin R. Wang, Wei Qian, Elysse S. Karozichian, Jennifer A. Philips, Rajendra S. Apte |
| 264 |
[GO] |
2020―Okt―20 |
High-density amplicon sequencing identifies community spread and ongoing evolution of SARS-CoV-2 in the Southern United States |
Ryan P. McNamara, Carolina Caro-Vegas, Justin T. Landis, Razia Moorad, Linda J. Pluta, Anthony B. Eason, Cecilia Thompson, Aubrey Bailey, Femi Cleola S. Villamor, Philip T. Lange, Jason P. Wong, Tischan Seltzer, Jedediah Seltzer, Yijun Zhou, Wolfgang Vahrson, Angelica Juarez, James O. Meyo, Tiphaine Calabre, Grant Broussard, Ricardo Rivera-Soto, Danielle L. Chappell, Ralph S. Baric, Blossom Damania, Melissa B. Miller, Dirk P. Dittmer |
| 265 |
[GO] |
2020―Okt―12 |
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes |
Tongqing Zhou, I-Ting Teng, Adam S. Olia, Gabriele Cerutti, Jason Gorman, Alexandra Nazzari, Wei Shi, Yaroslav Tsybovsky, Lingshu Wang, Shuishu Wang, Baoshan Zhang, Yi Zhang, Phinikoula S. Katsamba, Yuliya Petrova, Bailey B. Banach, Ahmed S. Fahad, Lihong Liu, Sheila N. Lopez Acevedo, Bharat Madan, Matheus Oliveira de Souza, Xiaoli Pan, Pengfei Wang, Jacy R. Wolfe, Michael Yin, David D. Ho, Emily Phung, Anthony DiPiazza, Lauren Chang, Olubukola M. Abiona, Kizzmekia S. Corbett, Brandon J. DeKosky, Barney S. Graham, John R. Mascola, John Misasi, Tracy Ruckwardt, Nancy J. Sullivan, Lawrence Shapiro, Peter D. Kwong |
| 266 |
[GO] |
2020―Sep―29 |
An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domain |
Nicholas C. Wu, Meng Yuan, Hejun Liu, Chang-Chun D. Lee, Xueyong Zhu, Sandhya Bangaru, Jonathan L. Torres, Tom G. Caniels, Philip J.M. Brouwer, Marit J. van Gils, Rogier W. Sanders, Andrew B. Ward, Ian A. Wilson |
| 267 |
[GO] |
2020―Sep―23 |
Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects |
Ya-Wen Cheng, Tai-Ling Chao, Chiao-Ling Li, Mu-Fan Chiu, Han-Chieh Kao, Sheng-Han Wang, Yu-Hao Pang, Chih-Hui Lin, Ya-Min Tsai, Wen-Hau Lee, Mi-Hua Tao, Tung-Ching Ho, Ping-Yi Wu, Li-Ting Jang, Pei-Jer Chen, Sui-Yuan Chang, Shiou-Hwei Yeh |
| 268 |
[GO] |
2020―Sep―19 |
Evasion of type-I interferon by SARS-CoV-2 |
Hongjie Xia, Zengguo Cao, Xuping Xie, Xianwen Zhang, John Yun-Chung Chen, Hualei Wang, Vineet D. Menachery, Ricardo Rajsbaum, Pei-Yong Shi |
| 269 |
[GO] |
2020―Sep―06 |
Activation of the SARS-CoV-2 receptor Ace2 through JAK/STAT-dependent enhancers during pregnancy |
Lothar Hennighausen, Hye Kyung Lee |
| 270 |
[GO] |
2020―Sep―04 |
SARS-CoV-2 ORF3b is a potent interferon antagonist whose activity is increased by a naturally occurring elongation variant |
Yoriyuki Konno, Izumi Kimura, Keiya Uriu, Masaya Fukushi, Takashi Irie, Yoshio Koyanagi, Daniel Sauter, Robert J. Gifford, So Nakagawa, Kei Sato |
| 271 |
[GO] |
2020―Sep―03 |
A single-cell RNA expression map of human coronavirus entry factors |
Manvendra Singh, Vikas Bansal, Cédric Feschotte |
| 272 |
[GO] |
2020―Jul―24 |
A carbohydrate-binding protein from the edible Lablab beans effectively blocks the infections of influenza viruses and SARS-CoV-2 |
Yo-Min Liu, Md. Shahed-Al-Mahmud, Xiaorui Chen, Ting-Hua Chen, Kuo-Shiang Liao, Jennifer M. Lo, Yi-Min Wu, Meng-Chiao Ho, Chung-Yi Wu, Chi-Huey Wong, Jia-Tsrong Jan, Che Ma |
| 273 |
[GO] |
2020―Jul―07 |
Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice. |
Andrea J. Pruijssers, Amelia S. George, Alexandra Schäfer, Sarah R. Leist, Lisa E. Gralinksi, Kenneth H. Dinnon, Boyd L. Yount, Maria L. Agostini, Laura J. Stevens, James D. Chappell, Xiaotao Lu, Tia M. Hughes, Kendra Gully, David R. Martinez, Ariane J. Brown, Rachel L. Graham, Jason K. Perry, Venice Du Pont, Jared Pitts, Bin Ma, Darius Babusis, Eisuke Murakami, Joy Y. Feng, John P. Bilello, Danielle P. Porter, Tomas Cihlar, Ralph S. Baric, Mark R. Denison, Timothy P. Sheahan |
| 274 |
[GO] |
2020―Jul―03 |
Potential causes and consequences of gastrointestinal disorders during a SARS-CoV-2 infection |
François Trottein, Harry Sokol |
| 275 |
[GO] |
2020―Jul―03 |
Human IgG neutralizing monoclonal antibodies block SARS-CoV-2 infection |
Jinkai Wan, Shenghui Xing, Longfei Ding, Yongheng Wang, Chenjian Gu, Yanling Wu, Bowen Rong, Cheng Li, Siqing Wang, Kun Chen, Chenxi He, Dandan Zhu, Songhua Yuan, Chengli Qiu, Chen Zhao, Lei Nie, Zhangzhao Gao, Jingyu Jiao, Xiaoyan Zhang, Xiangxi Wang, Tianlei Ying, Haibin Wang, Youhua Xie, Yanan Lu, Jianqing Xu, Fei Lan |
| 276 |
[GO] |
2020―Mai―30 |
Structural and biochemical characterization of nsp12-nsp7-nsp8 core polymerase complex from SARS-CoV-2 |
Qi Peng, Ruchao Peng, Bin Yuan, Jingru Zhao, Min Wang, Xixi Wang, Qian Wang, Yan Sun, Zheng Fan, Jianxun Qi, George F. Gao, Yi Shi |
| 277 |
[GO] |
2020―Mai―18 |
Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections |
Huibin Lv, Nicholas C. Wu, Owen Tak-Yin Tsang, Meng Yuan, Ranawaka A.P. M. Perera, Wai Shing Leung, Ray T.Y. So, Jacky Man Chun Chan, Garrick K. Yip, Thomas Shiu Hong Chik, Yiquan Wang, Chris Yau Chung Choi, Yihan Lin, Wilson W. Ng, Jincun Zhao, Leo L.M. Poon, J. S. Malik Peiris, Ian A. Wilson, Chris K.P. Mok |
| 278 |
[GO] |
2020―Mai―08 |
Publishing in a Pandemic: The View from Cell Reports |
The Cell Reports Editorial Team |
|
